Vascular disorder
MONDO:0005385A general term used to describe any disease affecting blood vessels]. It includes vascular abnormalities caused by degenerative, metabolic and inflammatory conditions, embolic diseases, coagulative disorders, and functional disorders such as posteri or reversible encephalopathy syndrome.
Also known as: disease of vasculature, disease or disorder of vasculature, disorder of vasculature, vascular disorder, vasculature disease, vasculature disease or disorder, vasculopathy
9271 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 1437 trials in this tab.
-
Magnetic brain zaps may restore movement after stroke
Disease control ENROLLING_BY_INVITATIONThis study tests a new non-invasive brain stimulation device called kTMP (kilohertz transcranial magnetic perturbation) to see if it can help improve arm and hand movement in people who have had a stroke. The trial involves 7 adults aged 18-80 who had a stroke at least 12 months …
Phase: NA • Sponsor: Magnetic Tides • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can Metal-Stripping infusions save diabetic limbs and hearts?
Disease control OngoingThis trial tests whether a chelation therapy infusion—a cocktail that removes toxic metals from the blood—can reduce the risk of heart attacks, strokes, and leg amputations in people with diabetes and critical limb ischemia (severe blockage in leg arteries). Half of the 50 partic…
Phase: PHASE3 • Sponsor: Mt. Sinai Medical Center, Miami • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New blood thinner cocktails aim to outsmart stroke in High-Risk patients
Disease control OngoingThis large phase 3 trial tests whether newer blood thinner combinations (ticagrelor plus aspirin or rivaroxaban plus aspirin) are better than the standard clopidogrel plus aspirin at preventing stroke, brain bleeding, or death from blood vessel disease. Over 1,600 participants wi…
Phase: PHASE3 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a Heart-Lung drug help kids with pulmonary hypertension?
Disease control OngoingThis study tests a drug called riociguat in children aged 6 to 18 who have pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe and move. The goal is to see if the drug is safe and how the body processes it at differen…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could botox in the heart stop Post-Surgery AFib?
Disease control OngoingThis study tests whether injecting botulinum toxin (Botox) into fat pads around the heart's veins during cardiac surgery can prevent atrial fibrillation (AFib), a common and serious complication. About 220 adults undergoing heart surgery will receive either Botox or a placebo inj…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Ultrasound device vs. blood thinners: which saves more lives from lung clots?
Disease control OngoingThis study tests two treatments for people with intermediate-high risk pulmonary embolism (a serious blood clot in the lungs). Half receive standard blood thinners, and the other half get blood thinners plus a special ultrasound device that helps dissolve the clot. Researchers wi…
Phase: PHASE4 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New antibody aims to dissolve lung clots with less bleeding risk
Disease control OngoingThis study tests a new drug called TS23, a monoclonal antibody designed to help break down blood clots in the lungs. It is for people with intermediate-risk pulmonary embolism, a serious condition where clots block blood flow. The trial compares different doses of TS23 against a …
Phase: PHASE2 • Sponsor: Translational Sciences, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a lower dose of a Clot-Buster be safer and still effective for dangerous blood clots in the lungs?
Disease control OngoingThis study tests whether a reduced dose of the clot-dissolving drug alteplase, given alongside standard blood thinners, can improve outcomes for people with intermediate-high-risk pulmonary embolism (a serious blood clot in the lungs). About 800 adults with confirmed acute pulmon…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New shot could stop dangerous swelling attacks in HAE
Disease control OngoingThis Phase 3 trial tests whether navenibart, a drug given as a shot under the skin, can prevent attacks in people with hereditary angioedema (HAE). About 145 adults and teens with HAE type 1 or 2 will receive either navenibart or a placebo for 6 months. The main goal is to see if…
Phase: PHASE3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a smartphone app replace the gym for heart rehab?
Disease control TerminatedThis trial tests whether a home-based tele-rehabilitation program is as effective as traditional center-based cardiac rehabilitation for people who have recently had a heart attack (acute coronary syndrome). Participants will either complete 20 sessions at a rehab center or 20 se…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New eye injection aims to halt diabetic vision loss
Disease control OngoingThis study tests an experimental drug called BI 764524, given as an eye injection, in 190 adults with moderate to severe diabetic retinopathy. Participants receive different numbers of injections over a year, and doctors compare eye damage improvements against a sham procedure or…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New stent aims to tackle tricky heart blockages
Disease control OngoingThis early study tests a new stent system designed to treat blockages at artery branch points in the heart. It involves 13 people with heart disease who need a procedure to open these blockages. The main goal is to see if the stent can be safely placed and work as intended.
Phase: NA • Sponsor: Advanced Bifurcation Systems Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New stent study aims to keep leg arteries open and prevent amputations
Disease control OngoingThis study is following 300 people with peripheral artery disease who received the MicroStent, a small mesh tube placed in leg arteries to improve blood flow. Researchers are tracking how well the arteries stay open over time and whether patients avoid major complications like am…
Sponsor: Micro Medical Solution, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New stroke drug HRS-7450 enters Mid-Stage trial
Disease control OngoingThis study tests an investigational drug called HRS-7450 in 208 people who have had an acute ischemic stroke within the past 4.5 to 24 hours. Participants receive either a low, intermediate, or high dose of the drug or a placebo. The goal is to see if the drug helps improve recov…
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Balloon battle: which coated catheter wins for tiny heart arteries?
Disease control OngoingThis trial tests two types of drug-coated balloon catheters to treat small, newly blocked heart arteries. About 180 adults with stable or unstable angina will be randomly assigned to receive one of the two devices during a standard angioplasty procedure. The goal is to see which …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New eye drug EYE103 takes on lucentis in major trial for Diabetes-Related vision loss
Disease control OngoingThis study tests a new drug called EYE103 (Restoret) against an existing treatment, ranibizumab (Lucentis), for people with diabetic macular edema, a condition that causes vision loss in diabetes. About 984 participants will receive injections into the eye every 4 weeks for a yea…
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a Two-Drug punch protect kidneys in High-Risk patients?
Disease control OngoingThis phase 3 study tests whether adding baxdrostat to the standard drug dapagliflozin can better slow chronic kidney disease (CKD) progression in adults with CKD and high blood pressure. About 2,500 participants will receive either the combination or dapagliflozin alone for 24 mo…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New eye drug EYE103 takes on standard treatment for Diabetes-Related vision loss
Disease control OngoingThis study tests a new drug called EYE103 (Restoret) against an existing treatment, ranibizumab (Lucentis), for people with diabetic macular edema, a common cause of vision loss in diabetes. About 1,054 participants receive injections into the eye every 4 weeks for a year, then l…
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New heart valve device tested in humans for first time
Disease control OngoingThis study tests a new device called the DurAVR™ THV System, a replacement heart valve placed through a small tube in an artery, for people with severe aortic stenosis (a narrowed heart valve). The trial involves 150 participants and aims to see if the device is safe and works we…
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New heart valve shows promise in early trial for aortic stenosis
Disease control OngoingThis early study tests a new device called the DurAVR™ heart valve in 15 people aged 65 and older with severe aortic stenosis, a condition where the heart's aortic valve becomes narrowed. The valve is implanted through a catheter (TAVR) without open-heart surgery. The main goals …
Phase: NA • Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a virtual blood pressure clinic keep your brain sharp?
Disease control OngoingThis study tests a virtual clinic where pharmacists monitor blood pressure, adjust medications, and provide telehealth support to older adults (65+) with high blood pressure. The goal is to see if better blood pressure control can also help prevent cognitive decline. About 1,000 …
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill aims to tame rare immune diseases
Disease control OngoingThis early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Implanted stimulator aims to restore walking after stroke
Disease control OngoingThis study tests an implanted electrical stimulator to improve walking in people who have had a stroke. Six participants will first be screened, then receive the implant and use it at home. Researchers will compare advanced control settings to a simple trigger to see which works …
Phase: NA • Sponsor: MetroHealth Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New balloon coated with drug aims to keep leg arteries open longer
Disease control OngoingThis study follows 284 people with blocked leg arteries (peripheral arterial disease) who are treated with a paclitaxel-coated balloon. The balloon is inflated inside the artery to open it and release a drug that helps prevent it from narrowing again. Researchers are tracking saf…
Sponsor: OrbusNeich • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Real-World study tests safety of new heart stents
Disease control OngoingThis study looks at how well Onyx drug-eluting stents work in everyday medical practice for people with coronary artery disease. Researchers will track 4,500 patients to see if these stents are safe and effective compared to other stents. The main focus is on preventing stent-rel…
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a Twice-Yearly shot stop artery plaque from growing?
Disease control OngoingThis study tests whether inclisiran, a drug given as a shot every 6 months, can reduce plaque buildup in the heart's arteries when added to standard statin therapy. About 608 adults with mild artery blockages (less than 50%) and no prior heart events will be randomly assigned to …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New Clot-Removing device tested in japan for dangerous blood clots
Disease control ENROLLING_BY_INVITATIONThis study is tracking 100 patients in Japan who receive the ClotTriever device to treat severe deep vein thrombosis (DVT). The device is used to remove blood clots from deep veins. Researchers are checking how safe the device is and how well it clears the clot in everyday hospit…
Sponsor: Inari Medical • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill aims to tame rare blood vessel disease
Disease control OngoingThis phase 2 trial tests whether adding the oral drug iptacopan to standard therapy (rituximab) helps people with active ANCA vasculitis achieve and maintain remission. About 84 adults with newly diagnosed or relapsed disease will receive either iptacopan or a placebo, plus stand…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Anti-Inflammatory shot near veins may stop blood clots from coming back
Disease control OngoingThis Phase 2 trial tests whether delivering the anti-inflammatory drug dexamethasone directly around deep veins can prevent blood clots from returning after they are removed. The study involves 60 adults aged 18-89 who have had DVT symptoms for 14-60 days. Participants receive ei…
Phase: PHASE2 • Sponsor: Mercator MedSystems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New digital rehab could bring heart recovery to your living room
Disease control OngoingThis study tests a 12-week home-based digital program called eCardiacRehab for people who have had a heart procedure (PCI). The program includes video messages, modules, and tracking to support recovery. Researchers want to see if patients will use it regularly and find it accept…
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Magnesium pills tested as simple blood pressure fix
Disease control OngoingThis study tests whether taking 480 mg of magnesium glycinate daily for 12 weeks can lower blood pressure in adults with slightly high systolic blood pressure (130-159 mmHg). 120 participants will be randomly assigned to get the supplement or a placebo. The main goal is to see if…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Less invasive heart valve replacement matches surgery in large trial
Disease control OngoingThis large study compared two treatments for severe aortic stenosis (a narrowed heart valve) in 1,746 patients at intermediate risk for surgery. One group got a less invasive procedure called TAVI (a new valve inserted through a tube in the artery), and the other had open-heart s…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Early rehab after heart attack may save lives and cut hospital visits
Disease control OngoingThis study looks at whether starting a cardiac rehabilitation programme soon after leaving the hospital helps people with coronary artery disease live longer and avoid hospital stays for heart problems. The programme includes counseling, education, and exercise sessions three tim…
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug aims to tame rare inflammatory disease
Disease control OngoingThis phase 3 trial tests whether a new drug, depemokimab, works as well as the current treatment mepolizumab for adults with a rare disease called EGPA, which causes inflammation of blood vessels. The study involves 163 participants and aims to see if depemokimab can help patient…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New inhaled drug shows promise for Long-Term control of rare lung disease
Disease control OngoingThis study looks at the long-term safety of an inhaled medication called seralutinib for people with pulmonary arterial hypertension (PAH), a serious condition where high blood pressure damages the arteries in the lungs. About 316 participants who finished a previous seralutinib …
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can mindfulness and diet ease the double burden on black women caregivers?
Disease control OngoingThis study tests two programs—mindfulness training and a heart-healthy diet plan—to help Black women caregivers lower their blood pressure and stress. About 90 participants will join weekly group sessions online for 8 weeks, with follow-up calls. The goal is to see if these appro…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New heart valve could save lives without Open-Heart surgery
Disease control OngoingThis trial is testing a new heart valve called SAPIEN X4/X4S in over 1,200 people with severe aortic stenosis, a condition where the heart's aortic valve narrows. The valve is inserted through a catheter, avoiding open-heart surgery. Researchers are measuring how many patients di…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Which diabetes drug best protects your heart? 60,000-person study aims to find out.
Disease control OngoingThis large study looks at real-world data from 60,000 people with type 2 diabetes and obesity to compare four diabetes drugs—dulaglutide, semaglutide, tirzepatide, and sitagliptin—in preventing heart attacks, strokes, and death. Researchers are analyzing insurance claims to see w…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Blood thinner safety check in kids after heart surgery
Disease control OngoingThis study looks at children with congenital heart disease who take the blood thinner rivaroxaban after a Fontan procedure. The goal is to see how often serious or minor bleeding happens. Researchers will collect data from regular doctor visits for up to 2 years. No extra tests o…
Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to fight Hard-to-Treat sarcomas
Disease control OngoingThis phase II trial tests two immunotherapy drugs, oleclumab and durvalumab, in 75 people with advanced sarcoma (angiosarcoma, dedifferentiated liposarcoma, or osteosarcoma) that has returned, spread, or stopped responding to treatment. The goal is to see if the combination can s…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New balloon treatment aims to clear blocked stents without extra surgery
Disease control OngoingThis study tests a special balloon coated with a drug to treat heart arteries that have narrowed again after a stent was placed. About 600 adults with this condition will be randomly assigned to receive either the drug-coated balloon or a standard balloon procedure. The goal is t…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill shows promise in early trial for Tough-to-Treat cancers
Disease control OngoingThis early-phase study tests an oral drug called IAG933 in adults with advanced mesothelioma and certain other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 13…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New shot aims to tackle hidden heart risk: high lp(a)
Disease control OngoingThis phase 2 trial tests an injectable drug called DII235 in 233 adults with high lipoprotein(a), a genetic condition that raises heart disease and stroke risk. Participants have heart disease or type 2 diabetes. The study compares different doses of DII235 against a placebo to s…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Tiny heart implant aims to ease strain in rare lung disease
Disease control OngoingThis early study tests a small, permanent device called the V-Wave Interatrial Shunt in 9 people with severe pulmonary arterial hypertension (PAH). The device is placed in the heart during a minimally invasive procedure to create a small opening between the upper chambers, which …
Phase: NA • Sponsor: V-Wave Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New balloon treatment aims to clear blocked stents without extra surgery
Disease control OngoingThis study tests a special balloon coated with the drug paclitaxel to treat in-stent restenosis, where a previously placed stent in a heart artery narrows again. Twenty adults who have this condition will receive the balloon treatment or standard care. Researchers will check if t…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New dissolving scaffold could save legs from amputation
Disease control OngoingThis study tests a new device called the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold for people with severe leg artery disease (critical limb ischemia). The scaffold slowly releases medicine to keep the artery open and then dissolves over time. Researchers compare it …
Phase: NA • Sponsor: REVA Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise against rare skin cancer
Disease control OngoingThis phase II trial tests the drug pomalidomide in about 45 people with Kaposi sarcoma, a rare skin cancer. Pomalidomide works by stopping blood vessel growth and boosting the immune system to fight cancer cells. The study aims to see how long tumors shrink and how many people re…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shot aims to slash heart attacks in 17,300 with hidden cholesterol risk
Disease control OngoingThis large Phase 3 study tests an injectable drug called lepodisiran in about 17,300 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease and stroke. Participants either already have heart disease or are at high risk for a first heart event. The goal…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart lasso: new catheter belt tightens leaky valve without surgery
Disease control TerminatedThis early study tests a new procedure called TRAIPTA for people with severe tricuspid valve regurgitation, a condition where a heart valve leaks and causes breathlessness and fluid buildup. The procedure uses a catheter to place a belt-like device around the heart from inside, t…
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sugar rush for stroke recovery? new trial tests fructose infusion
Disease control OngoingThis study tests whether giving a fructose (a type of sugar) injection soon after a stroke, along with standard clot-busting treatment, can improve brain recovery. About 46 adults who have a stroke within the last 4.5 hours will be randomly assigned to receive either fructose plu…
Phase: PHASE2 • Sponsor: Ji Xunming,MD,PhD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a new drug shield hearts and kidneys in overweight people?
Disease control OngoingThis phase 3 trial is testing whether the drug retatrutide can lower the chance of serious heart problems (like heart attacks and strokes) and slow kidney disease in 10,000 overweight adults who already have heart or kidney disease. Participants receive either retatrutide or a pl…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can home visits and texts tame Nepal's chronic disease crisis?
Disease control OngoingThis study tests whether home visits by female community health volunteers plus regular SMS messages can help adults in Pokhara, Nepal, better control high blood pressure, type 2 diabetes, and smoking. About 2100 participants are split into two groups: one gets the home visits an…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Promising CAR-T trial for kids with rare vasculitis pulled before start
Disease control TerminatedThis trial aimed to test whether anti-CD19 CAR-T cells could safely and effectively treat children with refractory ANCA-associated vasculitis, a rare autoimmune disease. The study was withdrawn before enrolling any participants, so no results are available. It was designed for ch…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a drug prevent gut problems and pneumonia in Brain-Injured patients?
Disease control TerminatedThis study tests whether naloxegol, a drug that blocks opioid effects in the gut, can prevent constipation and pneumonia in brain-injured patients in the ICU. These patients often receive opioids for sedation, which can slow digestion and lead to serious complications. The trial …
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Gene-Targeting drug could change how we treat high blood pressure
Disease control OngoingThis early-stage study tests a new drug called ADX-850 in 28 people with mild to moderate high blood pressure. The drug uses siRNA technology to target genes involved in blood pressure regulation. The main goal is to check safety and how the drug moves through the body, with a se…
Phase: PHASE1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New dissolving stent could save legs from amputation
Disease control OngoingThis early study tests a special scaffold that dissolves over time in 10 people with severe leg artery disease (critical limb-threatening ischemia). The scaffold is placed in arteries below the knee to help keep them open after balloon treatment. Researchers check safety and how …
Phase: NA • Sponsor: MeKo Manufacturing e.K. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a single pill replace two after heart implant? major trial seeks safer stroke prevention
Disease control OngoingThis study tests whether people with atrial fibrillation who receive a WATCHMAN FLX Pro device can safely take just one blood thinner or aspirin instead of the usual two-drug plan. About 1,857 participants are being followed for six months to compare rates of death, stroke, major…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New wireless device boosts stroke recovery by zapping nerves during rehab
Disease control ENROLLING_BY_INVITATIONThis study tests a wireless device that stimulates the vagus nerve during rehabilitation exercises to help people who have had a stroke recover arm and hand function. The approach, called targeted plasticity therapy, aims to enhance the brain's ability to rewire itself. The trial…
Phase: NA • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can an app lower your blood pressure? new study says maybe.
Disease control OngoingThis study tests a smartphone app called Liebria designed to help people manage high blood pressure. 328 adults with high blood pressure used the app at home to track and lower their readings. The goal is to see if the app can help control blood pressure and improve daily life.
Phase: NA • Sponsor: Gaia AG • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cord blood stroke trial pulled before it even started
Disease control TerminatedThis study planned to test whether giving a child their own stored umbilical cord blood is safe for treating perinatal arterial ischemic stroke. It was designed for children aged 6 weeks to 6 years with MRI-confirmed stroke. The trial was withdrawn before enrolling any participan…
Phase: PHASE1, PHASE2 • Sponsor: James Baumgartner, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for swelling disorder: experimental drug enters human trials
Disease control OngoingThis study tests a new drug called ADX-324 for hereditary angioedema (HAE), a rare genetic condition that causes sudden, severe swelling in the body. The trial has two parts: first, a small group of healthy volunteers will receive the drug to check its safety and how the body pro…
Phase: PHASE1, PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Faith and fitness: church program tackles high blood pressure
Disease control OngoingThis study tests a 6-month church-based program to help African Americans with uncontrolled high blood pressure. The program includes Bible study sessions led by the pastor and small group meetings focused on diet and exercise. A community health worker provides extra support if …
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart procedure timing trial aims to reduce complications
Disease control OngoingThis trial studies nearly 1,000 people with severe aortic stenosis and blocked coronary arteries who need both a valve replacement (TAVI) and artery stenting (PCI). Researchers want to see if doing the stenting before or after the valve replacement leads to fewer deaths, heart at…
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Shock wave device aims to smash heart artery calcium
Disease control OngoingThis study tests a new device that uses shock waves to break up calcium deposits in heart arteries before placing a stent. About 335 adults with coronary artery disease will receive this treatment at up to 55 US sites. The goal is to see if the device helps stents work better and…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Home monitoring and health coaches aim to stop high blood pressure before it starts
Disease control OngoingThis study tests a program where people with slightly high blood pressure use a home monitor and get support from a community health worker. The goal is to see if this helps keep blood pressure from rising to dangerous levels. About 600 adults from 20 health centers are taking pa…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a drug calm brain inflammation after stroke? new trial aims to find out
Disease control OngoingThis study tests whether adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency stroke treatment helps people recover better after a severe stroke caused by a large blood clot in the front part of the brain. About 692 adults who are el…
Phase: PHASE3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Weekly shot could replace daily needles for kids with growth disorders
Disease control OngoingThis study tests if a new growth hormone medicine (somapacitan) given once a week works as well as the standard daily growth hormone (Norditropin) for children who are very short due to being born small, or having Turner syndrome, Noonan syndrome, or unknown causes. About 412 chi…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Doulas and smart devices team up to tackle postpartum hypertension
Disease control OngoingThis study tests whether adding a specially trained doula, along with home blood pressure and weight monitoring, can improve blood pressure in women who had high blood pressure during pregnancy. About 454 women will be randomly assigned to usual care or the doula program. The goa…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could a tiny implant replace daily blood thinners for AFib patients?
Disease control OngoingThis large study is testing whether a device called WATCHMAN FLX, which closes off a small pouch in the heart, can be a safe and effective alternative to daily blood thinners (NOACs) for preventing strokes in people with non-valvular atrial fibrillation. The trial involves 3,000 …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for kids with rare cancers: drug targets tumor growth
Disease control OngoingThis phase 2 trial tests the drug cabozantinib in children and young adults with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. Cabozantinib works by blocking enzymes that help tumors grow and form blood vessels. The study a…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Glaucoma implant under the microscope: 5-Year safety watch begins
Disease control OngoingThis study follows 116 people with open-angle glaucoma who already have a MINIject implant in their eye. Researchers will track them for up to 5 years to see if any serious device-related problems occur. No new treatment is given—this is a safety check to see how well the implant…
Sponsor: iSTAR Medical • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Surgery vs. diet: which tames diabetes better?
Disease control OngoingThis study compares two types of weight-loss surgery (gastric bypass and gastric banding) with an intensive diet and exercise program for controlling type 2 diabetes in moderately obese adults aged 25 to 55. The goal is to see which approach works best for improving diabetes and …
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New coil aims to plug brain aneurysms more safely and cheaply
Disease control OngoingThis study tests a new coil device (Kaneka i-ED) in 50 people with wide-necked brain aneurysms. The coil is placed inside the aneurysm to block blood flow and prevent rupture. Researchers will check how well it works, how safe it is, and whether it saves money compared to standar…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New balloon coated with paclitaxel aims to keep brain arteries open
Disease control OngoingThis study tests a special balloon catheter coated with the drug paclitaxel to treat narrowed or re-narrowed brain arteries. The balloon is inflated inside the artery to open it and release the drug, which may help prevent the artery from closing again. The trial includes 281 adu…
Phase: NA • Sponsor: B. Braun Medical International Trading Company Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Stent vs. scalpel: can a tiny tube replace surgery for leg artery disease?
Disease control OngoingThis study compares a new stent (Supera) to standard surgery for treating blockages in the leg's main artery. About 286 people with moderate to severe leg pain or sores will be randomly assigned to get either the stent or surgery. Researchers will check if the stent keeps the art…
Phase: NA • Sponsor: KANDO Research • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Genetic risk + drug combo may halt silent heart disease
Disease control OngoingThis study tests whether a high-intensity statin and a low-dose anti-inflammatory drug (colchicine) can slow the buildup of artery plaque in people with a high genetic risk for heart disease. Researchers will use CT scans to measure changes in plaque over one year. The trial invo…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New heart pump could replace ECMO in risky angioplasty
Disease control OngoingThis trial tests whether a new device called OmniHeart 4.0 can safely support the heart during high-risk angioplasty, compared to the standard ECMO machine. About 254 patients will be randomly assigned to receive either the OmniHeart or ECMO. Researchers will track major heart an…
Phase: NA • Sponsor: Shanghai Dynaheart Medtech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Balloon battle: which device keeps leg arteries open longer?
Disease control OngoingThis study tests whether a new drug-coated balloon (Passeo-18 Lux) is as safe and effective as an existing one (IN.PACT Admiral) for opening blocked leg arteries in people with peripheral artery disease. About 302 participants with moderate to severe symptoms are randomly assigne…
Phase: NA • Sponsor: KANDO Research • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a new eye drop boost laser results for glaucoma patients?
Disease control OngoingThis study tests whether Rhopressa eye drops can further lower eye pressure in people with glaucoma or high eye pressure who recently had laser surgery (SLT) in both eyes. About 70 adults will receive either Rhopressa or placebo drops daily for several weeks. The goal is to see i…
Phase: PHASE4 • Sponsor: East Coast Institute for Research • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis study tests a daily oral drug called nemtabrutinib (ARQ 531) in 190 people with blood cancers like lymphoma or leukemia that have come back or not responded to prior treatment. The goal is to find a safe dose and see if the drug can shrink tumors. It is an early-phase trial,…
Phase: PHASE1, PHASE2 • Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Heart drug trial aims to cut deadly attacks
Disease control OngoingThis large Phase 3 trial is testing whether a drug called inclisiran can reduce major heart problems like heart attacks and strokes in people who already have heart disease. About 17,000 participants are taking either inclisiran or a placebo, along with their usual cholesterol-lo…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New study monitors eylea in premature Babies' eye disease
Disease control OngoingThis study follows 75 Japanese babies with retinopathy of prematurity (ROP) who are being treated with Eylea, a drug injected into the eye. ROP causes abnormal blood vessel growth in the retina and can lead to blindness. The study collects real-world data on side effects and how …
Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
App-based coaching aims to tame hypertension
Disease control OngoingThis study tests a mobile app called HyperCoach that provides health coaching to help people with high blood pressure manage their condition. Thirty-seven adults with hypertension who are already on medication will use the app to track blood pressure, weight, and steps, and set p…
Phase: NA • Sponsor: Texas A&M University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Heart-Lung hope: new drug sotatercept tested for tough hypertension
Disease control OngoingThis study looks at the long-term safety of a drug called sotatercept for people with a specific type of pulmonary hypertension caused by heart failure with preserved ejection fraction. About 130 people who completed a prior study will receive sotatercept injections and be monito…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental biologic aims to stop recurrent clots in antiphospholipid syndrome
Disease control OngoingThis early-phase trial tests an investigational biologic called EA5 in adults with antiphospholipid syndrome (APS) who have had two or more blood clots despite standard blood-thinning therapy. The study enrolls about 12 participants and gives EA5 by intravenous infusion followed …
Phase: PHASE1 • Sponsor: Shanghai Lanyi Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New heart valve offers hope for High-Risk patients
Disease control OngoingThis study tests a next-generation heart valve (Navitor) in 333 people with severe aortic stenosis who are too high-risk for open-heart surgery. The goal is to see if the valve is safe and works well at 30 days, focusing on survival and reducing leaks around the valve. The valve …
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New program aims to tackle heart disease in pasifika populations
Disease control ENROLLING_BY_INVITATIONThis study tests a 3-month lifestyle program called the PILI Pasifika Program for Native Hawaiian and Pacific Islander adults who are overweight or have conditions like high blood pressure or diabetes. The program includes group lessons on healthy eating and physical activity, pl…
Phase: NA • Sponsor: University of Hawaii • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a new dose of selexipag help kids with rare lung disease?
Disease control OngoingThis study is testing the safety and right dose of a drug called selexipag in children aged 2 to 17 with pulmonary arterial hypertension (PAH), a serious condition where blood pressure in the lungs is too high. The goal is to find a dose that works like the adult version. The stu…
Phase: PHASE2 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Major trial pits drugs vs. surgery vs. stents for failing hearts
Disease control TerminatedThis phase 3 trial studies 1,200 people with severe coronary artery disease and a weak heart pump (ejection fraction 40% or less). Participants are randomly assigned to receive either guideline-directed medical therapy, bypass surgery, or stenting. The study tracks survival, hear…
Phase: PHASE3 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could this pill help kids with rare lung disease?
Disease control OngoingThis study tests whether adding selexipag to standard treatment can delay disease worsening in children aged 2 to 18 with pulmonary arterial hypertension (PAH). About 138 children will receive either selexipag or a placebo, plus their usual medications. The main goal is to see if…
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New stent aims to fix dangerous aortic bulges without major surgery
Disease control OngoingThis study tests a special stent device (GORE EXCLUDER) to treat thoracoabdominal and pararenal aortic aneurysms—bulges in the main artery that can rupture. About 102 people will receive the stent through a minimally invasive procedure. Researchers will check if the device is pla…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New pill aims to cut stroke risk without the bleeding worry
Disease control OngoingThis large Phase 3 study tests whether milvexian, an experimental oral blood thinner, can prevent another stroke in people who recently had a mild stroke or a high-risk mini-stroke (TIA). Over 12,500 participants are randomly assigned to receive either milvexian or a placebo, alo…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug cocktail shows promise for rare HIV-Linked cancer
Disease control OngoingThis early-phase trial tested whether combining two anti-cancer drugs, pomalidomide (taken as a pill) and liposomal doxorubicin (given through an IV), is safe and tolerable for people with advanced or hard-to-treat Kaposi sarcoma. The study enrolled 62 adults, including those wit…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Eye implant could replace monthly shots for diabetes-related vision loss
Disease control OngoingThis study tests a small, refillable implant placed in the eye that delivers medication every 24 weeks, compared to standard monthly eye injections. It includes about 634 adults with diabetic macular edema, a condition that causes vision loss. The goal is to see if the implant wo…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New eye drug shows promise for Diabetes-Related vision loss
Disease control OngoingThis early-stage study tests a new drug, RO7497372, given as an eye injection for people with diabetic macular edema (DME), a condition that causes vision loss. The trial involves 151 participants and aims to check the drug's safety, how long it stays in the eye and blood, and it…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New device aims to seal brain aneurysms safely
Disease control OngoingThis study looks at a device called ENTERPRISE 2 that helps doctors treat brain aneurysms (a bulging blood vessel in the brain). The device is used during a procedure to block the aneurysm with coils. The study includes 164 people aged 18 to 80 with certain types of brain aneurys…
Sponsor: Medos International SARL • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New heart device aims to cut stroke risk in AFib patients
Disease control TerminatedThis study tests a new device (Laminar) to close the left atrial appendage, a small pouch in the heart, in 1500 people with non-valvular atrial fibrillation. The goal is to see if it is safer and works better than existing devices to reduce the risk of stroke and blood clots. Par…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Higher dose of PAH drug may keep patients out of hospital longer
Disease control OngoingThis phase 3 trial compares two doses of macitentan (75 mg vs 10 mg) in about 935 adults with pulmonary arterial hypertension. The goal is to see if the higher dose can delay serious events like hospitalization or death. Participants will be followed for several years.
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New camera could save hearts: OCTAVE trial tests smarter stent placement
Disease control ENROLLING_BY_INVITATIONThis study tests whether using a special camera (OCT) inside the heart's arteries during a heart attack procedure leads to better outcomes than the standard X-ray method. About 3000 people having a heart attack will be randomly assigned to one of the two approaches. The goal is t…
Phase: NA • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Grocery money may lower blood sugar and blood pressure in low-income patients
Disease control OngoingThis study looks at whether giving low-income people with diabetes or hypertension a monthly grocery card ($80 or $120) helps them control their disease and feel less stressed about food. About 4,450 adults in California are taking part. Researchers will check changes in blood su…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Supplement shows promise for kidney Patients' heart health
Disease control OngoingThis study tests whether a natural supplement called nicotinamide riboside can improve artery stiffness and lower blood pressure in people with moderate to severe chronic kidney disease. About 118 adults aged 35-80 will take either the supplement or a placebo for 3 months. The go…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Groceries as medicine: new study tests food prescriptions for heart health
Disease control ENROLLING_BY_INVITATIONThis study looks at whether providing medically tailored groceries can help people with type 2 diabetes and high blood pressure keep up healthy eating habits and control their blood sugar and blood pressure. About 80 adults who already took part in a meal delivery study will rece…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New chimney graft study aims to fix tricky aortic aneurysms without open surgery
Disease control OngoingThis study tests a special chimney graft technique for people with a type of aortic aneurysm that is hard to treat because it is close to the kidneys. The goal is to see if this method is safe and works well in everyday medical practice. About 150 adults will take part, and resea…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New device aims to prevent clots in stroke patients
Disease control OngoingThis pilot study tests a new device called OsciPulse that rapidly compresses the calves to improve blood flow and reduce the risk of blood clots in people hospitalized after a stroke. About 40 adults with leg weakness will be randomly assigned to receive either OsciPulse or stand…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for HAE: Long-Term trial of navenibart launches
Disease control ENROLLING_BY_INVITATIONThis Phase 3 trial tests the long-term safety and effectiveness of navenibart, an injectable drug, in 145 adults and teens with hereditary angioedema (HAE) who were in a previous study. The trial has two parts: first, everyone gets a fixed dose; then, some may switch to a persona…
Phase: PHASE3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Migraine drug atogepant tested in everyday life
Disease control OngoingThis study looks at how well the migraine prevention drug atogepant works in real-world settings. Over 1000 adults with migraine who are already prescribed atogepant will be followed for 2 years. Researchers will measure how much patients feel their migraines have improved since …
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for rare cancer: immune booster plus chemo shows promise
Disease control OngoingThis phase II trial tests whether adding the immunotherapy drug nivolumab to the chemotherapy paclitaxel helps shrink tumors in people with angiosarcoma who haven't had taxane drugs before. For those who have already received taxanes, the trial tests a combination of nivolumab an…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can a Triple-Dose of ICU tweaks save more brains after cardiac arrest?
Disease control OngoingThis study looks at 3,500 unconscious patients who survived a cardiac arrest to find the best combination of sedation, fever control, and blood pressure management in the ICU. Each patient gets one of two levels for each factor (e.g., deep vs. light sedation, tight vs. loose feve…
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New Nurse-Led telemonitoring program aims to keep seniors with multiple health issues out of the hospital
Disease control OngoingThis study tests a nurse-led program that uses home monitoring devices to help older adults with conditions like heart failure, diabetes, and depression manage their health after leaving the hospital. The goal is to improve care coordination and reduce hospital readmissions. Abou…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can churches help close the heart health gap? new study tests community approach
Disease control OngoingThis study tests whether a church-based program led by community health workers can help Black adults in Louisiana lower their risk of heart disease, high blood pressure, diabetes, and high cholesterol. About 812 participants from local churches will receive either a health worke…
Phase: NA • Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Doctors get report cards: will peer pressure lower blood pressure?
Disease control OngoingThis study tests whether sending primary care doctors a monthly report comparing their hypertension control rates to peers can improve patient care. About 93 doctors and their patients with high blood pressure are involved. The goal is to see if this feedback leads to more medica…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Sound waves vs. scalpel: new study tests shockwave therapy for blocked leg arteries
Disease control OngoingThis study compares a new, less invasive shockwave device to standard surgery for treating severe calcium buildup in the main leg artery. The shockwave uses sound waves to break up the calcium, while surgery involves physically removing the blockage. Researchers want to see if th…
Phase: NA • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New heart implant aims to cut stroke risk without blood thinners
Disease control OngoingThis study tests a device called Amulet 2 that is implanted in the heart to seal off a small pouch (the left atrial appendage) where blood clots can form in people with atrial fibrillation. The goal is to reduce the risk of stroke without needing long-term blood thinners. About 4…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gut feeling: personalized bacteria may ease PTSD symptoms
Disease control OngoingThis study looks at whether giving people with PTSD a personalized mix of gut bacteria (called pharmabiotics) can help their mental health. The researchers will track changes in PTSD symptoms, anxiety, depression, and thinking skills over 14 days. The goal is to see if fixing the…
Phase: NA • Sponsor: Uzhhorod National University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New program aims to tackle high blood pressure in black communities
Disease control ENROLLING_BY_INVITATIONThis study tests a program called PACE that combines nurse support, remote blood pressure monitoring, and help with social needs (like housing or food) to improve blood pressure control in Black patients. About 500 adults with uncontrolled high blood pressure will take part acros…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Common antibiotic may shield Kids' hearts from kawasaki disease damage
Disease control OngoingThis study tests whether the antibiotic doxycycline can prevent or slow the enlargement of heart arteries in children with Kawasaki disease. About 26 children with already enlarged coronary arteries will receive doxycycline for three weeks. The goal is to see if the drug blocks a…
Phase: PHASE2 • Sponsor: Hawaii Pacific Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cholesterol drug inclisiran tracked in belgian heart patients
Disease control OngoingThis study follows 600 Belgian adults with atherosclerotic cardiovascular disease who are prescribed inclisiran, a cholesterol-lowering injection, alongside their usual medications. Researchers will measure how much LDL cholesterol drops and how many patients reach their target l…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New shot could replace daily pills for hypertension
Disease control OngoingThis study tests an experimental drug called QCZ484, given as an injection under the skin every 6 months, for people with mild to moderate high blood pressure. About 385 adults aged 18 to 75 are taking part. The goal is to see if the drug safely lowers blood pressure compared to …
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Weekly pill could help shed pounds in obesity trial
Disease control OngoingThis phase 2b trial tests a weekly oral tablet called ecnoglutide (VRB-101) for weight loss in 206 adults with obesity or overweight plus weight-related health problems. Participants receive either the drug or a placebo for several weeks. The main goal is to see how much body wei…
Phase: PHASE2 • Sponsor: Verdiva Bio Dev Limited • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart valve showdown: which TAVR device wins for small aortas?
Disease control OngoingThis study compares two types of TAVR devices (self-expanding vs. balloon-expandable) in over 1,100 people with severe aortic stenosis and a small aortic annulus. The goal is to see which device leads to fewer deaths, strokes, or hospitalizations, and which performs better over t…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Community health workers take on high blood pressure and diabetes in the andes
Disease control OngoingThis study tests whether monthly home visits from trained health agents can help people in poor, high-altitude communities in Peru better control their high blood pressure and diabetes. Over 1,000 participants will either receive these visits for a year or get usual care. The goa…
Phase: NA • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug could cut repeat eye surgeries in diabetics
Disease control ENROLLING_BY_INVITATIONThis study tests whether the drug farcimab (Vabysmo), given as an injection before and after eye surgery, can reduce bleeding complications in people with diabetes who have bleeding inside the eye. About 100 adults will receive either farcimab or a sham injection. The goal is to …
Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Double vision for heart stents: could two scans beat one?
Disease control OngoingThis study compares two strategies for placing stents in people with multiple blocked heart arteries. One group gets standard guidance using a pressure wire (FFR), while the other also uses an imaging catheter (OCT) to spot unstable plaques. The goal is to see if the combined app…
Phase: NA • Sponsor: Diagram B.V. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a direct brain artery injection improve stroke recovery?
Disease control ENROLLING_BY_INVITATIONThis phase 2 trial tests whether giving the clot-busting drug tenecteplase directly into the brain artery after standard clot removal is safe and feasible for people with severe stroke. About 40 participants who had a large artery blockage will receive either the drug or a saltwa…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New stent graft could fix Life-Threatening aorta tears without open surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a special tube called a stent graft to repair damage in the upper part of the main artery from the heart (the ascending aorta). It is for people with bulges (aneurysms), tears (dissections), or other lesions that usually need open-heart surgery. The goal is to se…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New device sucks out dangerous blood clots in leg veins
Disease control OngoingThis study is testing a device called the Indigo Aspiration System that suctions out blood clots in people with deep vein thrombosis (DVT) in the leg. The goal is to see if it safely and effectively removes the clot and restores blood flow. About 229 participants with recent DVT …
Phase: NA • Sponsor: Penumbra Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can lowering cholesterol more aggressively help seniors with heart disease?
Disease control OngoingThis study compares two cholesterol-lowering strategies in adults aged 75 and older who have heart or blood vessel disease. One group aims for a very low LDL cholesterol target (below 55 mg/dL) using high-intensity statins, while the other receives standard moderate-intensity sta…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a Triple-Drug combo save Women's hearts when arteries look clear?
Disease control OngoingThis study tests whether a combination of high-dose statins, blood pressure medications (ACE inhibitors or ARBs), and low-dose aspirin can reduce the risk of death, heart attack, stroke, or hospitalization in women who have chest pain or shortness of breath but no major blockages…
Phase: PHASE4 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New daily pill could lower blood pressure and weight at the same time
Disease control OngoingThis Phase 3 trial tests a daily pill called orforglipron in 487 adults with high blood pressure who are also overweight or obese. The study measures how well the drug lowers blood pressure and body weight compared to a placebo. It is currently active but not recruiting.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug inclisiran aims to lower cholesterol better in chinese heart patients
Disease control OngoingThis study tests whether inclisiran, a newer cholesterol-lowering drug, works better than standard treatments for Chinese patients with coronary heart disease. About 1,590 adults whose cholesterol is still high despite statins will receive either inclisiran or usual care. The mai…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New daily pill could help control blood pressure in overweight individuals
Disease control OngoingThis Phase 3 trial is testing a once-daily pill called orforglipron in nearly 1,000 people with high blood pressure who are also overweight or have obesity. The study compares the drug to a placebo to see if it safely lowers blood pressure. Participants may be untreated or on sta…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New daily pill aims to lower blood pressure and weight in one go
Disease control OngoingThis Phase 3 study tests an experimental once-daily pill called orforglipron in about 487 adults who have both high blood pressure and obesity or overweight. The main goal is to see if the drug lowers blood pressure more than a placebo. Researchers will also check for changes in …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Bone-Moving surgery could help avoid amputation in 'No Option' patients
Disease control TerminatedThis study was designed to test a new surgical technique called transverse tibial bone transport in people with chronic limb-threatening ischemia (CLTI) who have no standard treatment options left. The procedure involves slowly moving a small piece of shinbone to stimulate new bl…
Phase: NA • Sponsor: University Hospitals Cleveland Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One shot to lower blood pressure? early trial begins
Disease control OngoingThis early-phase study tests a single injection of ART101 in 16 adults with high blood pressure. The goal is to see if it is safe and how it affects blood pressure over 24 weeks. Participants receive either 600 mg or 800 mg of the drug and are closely monitored.
Phase: PHASE1 • Sponsor: Arnatar Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Balloon or stent? major trial tests safer option for clogged heart arteries
Disease control OngoingThis study tests whether a drug-coated balloon is as safe and effective as a drug-eluting stent for people with large coronary artery disease. About 1,400 participants from multiple countries will be randomly assigned to one of the two treatments. The goal is to see which approac…
Phase: NA • Sponsor: B. Braun Medical Industries Sdn. Bhd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Chilled magnesium may boost stroke recovery in new trial
Disease control ENROLLING_BY_INVITATIONThis study tests whether infusing a cold magnesium sulfate solution directly into the brain during emergency clot removal can improve outcomes for people with acute ischemic stroke. About 42 adults aged 18-80 with severe strokes will be randomly assigned to receive either standar…
Phase: PHASE1, PHASE2 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New eye injection shows promise for blinding swelling
Disease control OngoingThis early-stage study tests a new drug called EYE201, given as three eye injections over 12 weeks, to see if it is safe and can help reduce swelling in the back of the eye. It includes people with three different eye conditions that cause vision loss: branch retinal vein occlusi…
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New combo therapy tackles cancer in HIV patients
Disease control OngoingThis early-phase trial tests the safety of combining two cancer drugs, nivolumab and cabozantinib, in people with HIV who have advanced solid tumors. Only 8 participants were enrolled. The goal is to see if the combination is safe and can shrink or stabilize tumors.
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New inhaled powder shows promise for Long-Term PAH control
Disease control OngoingThis study is testing the long-term safety and tolerability of an inhaled treprostinil powder (TPIP) in people with pulmonary arterial hypertension (PAH). About 91 participants who completed earlier TPIP studies will receive the drug for up to several years. Researchers will moni…
Phase: PHASE2, PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New program aims to boost health in people with disabilities
Disease control OngoingThis study tests a health support program for 600 people with disabilities who also have chronic conditions like diabetes or obesity. The program includes weekly nutrition classes, three exercise sessions per week, and help managing chronic conditions. Researchers want to see if …
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for rare disease: can NS-229 help patients reduce steroids?
Disease control OngoingThis study tests a new medicine, NS-229, in 45 adults with a rare disease called eosinophilic granulomatosis with polyangiitis (EGPA), which causes inflammation in blood vessels. The goal is to see if NS-229 can help patients achieve remission while lowering their daily steroid d…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Eye drops may halt worsening nearsightedness in adults
Disease control OngoingThis study tests whether eye pressure-lowering medication can slow the progression of severe nearsightedness (high myopia) in adults. Researchers will measure changes in eye length and vision over time. The trial includes 152 participants aged 18 to 65 with worsening high myopia …
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New eye drug trial focuses on black, hispanic, and native american patients
Disease control OngoingThis study tests a drug called faricimab (VABYSMO) in 218 people with diabetic macular edema who have not been treated before. The participants are Black/African American, Hispanic/Latino American, Native American/Alaska Native/Native Hawaiian/Pacific Islander, or Asian Indian. T…
Phase: PHASE4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Shockwave stent trial pulled before it began
Disease control TerminatedThis study planned to test a special shockwave device that uses sound waves to crack calcium buildup in leg arteries before placing a stent. The goal was to improve stent fit and long-term blood flow in people with severe peripheral artery disease. However, the trial was withdraw…
Sponsor: Cardiovascular Institute of the South Clinical Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Blood test may prevent clots after leg surgery
Disease control OngoingThis study looks at whether a special blood test (TEG-PM) can guide doctors in adjusting blood-thinning medications for people who have had leg artery surgery for peripheral artery disease. About 130 adults will have their blood tested before and up to 9 months after surgery, and…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New eye injection shows promise for Diabetes-Related vision loss
Disease control OngoingThis study tests a new eye injection called IBI302 for people with diabetic macular edema, a condition that causes vision loss due to diabetes. About 150 adults aged 18-80 with type 1 or 2 diabetes and swelling in the center of the retina will receive either IBI302 or an active c…
Phase: PHASE2 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New stent graft study aims to improve aneurysm repair outcomes
Disease control OngoingThis study follows 164 people with abdominal aortic aneurysm who receive the Ankura stent graft system, a device placed inside the aorta to reinforce the weakened area. Researchers will track major complications and treatment success over 12 months. The goal is to see how well th…
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Coaching by nurses shows promise for blood pressure control in rural china
Disease control ENROLLING_BY_INVITATIONThis study tests whether nurse-led health coaching can help adults with high blood pressure in Huayuan County, China, better manage their condition. About 78 participants will receive either standard care or additional coaching sessions over six months. The goal is to see if coac…
Phase: NA • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New stent graft under scrutiny for aortic repair
Disease control OngoingThis study is following 147 people who have a bulge (aneurysm) or tear (dissection) in the main artery of the chest. All participants received the Ankura stent graft, a fabric-covered metal tube placed inside the artery to support it. Researchers are tracking how well the device …
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Exercise as medicine: 10-week program targets diabetes and high blood pressure in seniors
Disease control OngoingThis study looks at whether 10 weeks of regular exercise (on land or in water) can lower blood sugar and blood pressure in people aged 60 and older who have several health conditions like diabetes, high blood pressure, and arthritis. 63 volunteers will be split into two exercise …
Phase: NA • Sponsor: Universidade do Porto • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New weekly shot could help severely obese heart patients shed pounds
Disease control OngoingThis Phase 3 study tests a weekly injection called retatrutide in about 1,946 people with severe obesity (BMI ≥35) and established heart disease. The goal is to see if it helps with weight loss and improves heart-related health measures over 113 weeks compared to a placebo. Parti…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New heart device aims to prevent strokes in patients with a hole in the heart
Disease control OngoingThis study tests a new device called the Occlutech Flex II PFO Occluder, which is used to close a small hole in the heart (PFO) that can cause strokes. The trial involves 450 people who have had a stroke with no clear cause and a PFO. Researchers want to see if the new device wor…
Phase: NA • Sponsor: Occlutech International AB • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to tame Cushing's disease with fewer side effects
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding cabergoline to osilodrostat works better than osilodrostat alone for controlling Cushing's disease. About 50 adults with active Cushing's disease will receive either the combination or the single drug. The goal is to see if the combo can lower cort…
Phase: PHASE4 • Sponsor: University of Basrah • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Brain AVM drug trial pulled before it began
Disease control TerminatedThis pilot study aimed to see if the oral drug trametinib could improve the structure of brain arteriovenous malformations (AVMs) in adults before their scheduled surgery. The goal was to shrink the AVM or reduce risky features. However, the trial was withdrawn before enrolling a…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New pill aims to tame stubborn high blood pressure
Disease control ENROLLING_BY_INVITATIONThis study tests a new daily pill called QLS1410 in 260 adults whose high blood pressure remains high despite taking two or more medications. Participants will receive either QLS1410 or a placebo for 12 weeks. The main goal is to see if QLS1410 can lower systolic blood pressure m…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New laser shows promise for varicose vein treatment in Head-to-Head trial
Disease control OngoingThis phase 3 trial compares two laser wavelengths (1940 nm vs 1470 nm) for closing off faulty veins in people with symptomatic varicose veins. 220 adults will be randomly assigned to one laser or the other. The main goal is to see which laser achieves complete vein closure at 6 m…
Phase: PHASE3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a lifestyle clinic help people with obesity? large trial launches
Disease control ENROLLING_BY_INVITATIONThis trial tests a 12-month lifestyle medicine program for 1000 adults with obesity and related conditions like diabetes or high blood pressure. Participants get regular visits with a dietitian and a doctor, plus optional behavioral health support. The goal is to see if the progr…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Inhaled sirolimus trial aims to ease breathing in lung scar patients
Disease control OngoingThis Phase 2 trial tests an inhaled drug called LAM-001 (sirolimus) in 85 adults who have pulmonary hypertension (high blood pressure in the lungs) along with interstitial lung disease (lung scarring). The study compares the drug to a placebo to see if it improves blood flow in t…
Phase: PHASE2 • Sponsor: OrphAI Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Sound wave device aims to improve heart stent success in women
Disease control OngoingThis study is testing a device that uses sound waves (intravascular lithotripsy) to break up hard calcium deposits in the heart arteries of women with coronary artery disease. The goal is to make it easier to place stents and improve outcomes. About 400 women are being followed t…
Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a Plant-Based diet protect transplanted kidneys?
Disease control OngoingThis study looks at whether switching to a plant-based diet can improve heart health and reduce inflammation in people who have had a kidney transplant. Twenty-five participants who are at least three months post-transplant will follow a plant-based diet for 16 weeks after a two-…
Phase: NA • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could an implant replace daily eye drops for glaucoma?
Disease control OngoingThis study tests an implant called AGN-193408 SR that is placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 100 participants will receive the implant, and some will also get standard eye drops for comparison. The goal is to se…
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug aims to shield kidneys from dye damage during heart surgery
Disease control OngoingThis study tests whether the drug APX-115 can prevent kidney injury caused by contrast dye used in heart procedures. About 230 adults with kidney disease will receive either the drug or a placebo before and after their procedure. The goal is to see if the drug reduces kidney dama…
Phase: PHASE2 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for heart patients: less invasive valve procedure tested for moderate stenosis
Disease control OngoingThis study tests whether a less invasive heart valve replacement (TAVR) is safe and effective for people with moderate aortic stenosis, a condition where the heart's aortic valve is partially blocked. About 650 participants will receive the TAVR device and be monitored for compli…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New laser could ease glaucoma without drops
Disease control OngoingThis study tests a new laser procedure called Direct Selective Laser Trabeculoplasty (DSLT) in 40 ethnic Chinese patients with glaucoma or high eye pressure. The laser aims to improve fluid drainage in the eye and reduce pressure. Researchers will check if the treatment is safe a…
Phase: NA • Sponsor: BelkinVision • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Less invasive heart valve fix vs. open surgery: which is better for High-Risk patients?
Disease control ENROLLING_BY_INVITATIONThis study compares two procedures for severe aortic valve stenosis: transcatheter aortic valve implantation (TAVI), a less invasive approach, and standard open-heart surgery. It will follow 4,000 high-risk patients for up to 24 months to see which method leads to fewer deaths, h…
Sponsor: Centre Cardiologique du Nord • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New catheter aims to clear Hard-to-Treat heart blockages
Disease control ENROLLING_BY_INVITATIONThis study tests a new device called the Acolyte Catheter System in people with completely blocked heart arteries (chronic total occlusions) who still have symptoms despite medication. The goal is to see if the catheter can safely help doctors guide wires through the blockage to …
Phase: NA • Sponsor: Elumn8 Medical • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug candidate targets Hard-to-Treat lung condition
Disease control OngoingThis early-stage study by Pfizer tests a new drug called PF-07868489. First, it will be given to healthy volunteers to check safety and how the body processes it. Then, people with pulmonary arterial hypertension (PAH) will receive repeated doses over 24 weeks to see if it helps …
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Home workouts after stroke: a new hope for recovery?
Disease control OngoingThis study tests whether a structured exercise program done at home can improve walking ability and overall recovery in people who recently had a stroke. About 208 adults who had a stroke within the past two weeks will be assigned to either the home exercise program or usual care…
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a weekly shot slash heart attack risk? major trial underway
Disease control OngoingThis study tests whether a weekly injection of CagriSema (a combination of two drugs) can reduce the risk of heart attacks, strokes, and other heart-related events in people with established cardiovascular disease. About 7,100 participants will receive either CagriSema or a place…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Ultrasound zaps lung nerves to ease heart failure symptoms
Disease control ENROLLING_BY_INVITATIONThis early study is testing a device that uses ultrasound to ablate (calm) nerves in the pulmonary artery. The goal is to see if this procedure can improve quality of life for 50 people with heart failure and a specific type of pulmonary hypertension (Group 2). Participants will …
Phase: NA • Sponsor: Gradient Denervation Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Smaller liver grafts could revolutionize transplant safety
Disease control ENROLLING_BY_INVITATIONThis study looks at a new way to do liver transplants for people with severe portal hypertension. Instead of using a full-sized liver, doctors will use a smaller piece (small-for-size graft) in an auxiliary transplant, leaving part of the original liver in place. The goal is to s…
Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Sound waves to zap high blood pressure: new device trial begins
Disease control OngoingThis study tests a device called TIVUS that uses ultrasound to calm overactive nerves in the kidneys, which can drive high blood pressure. It includes 25 adults with uncontrolled stage 2 hypertension who have not responded well to medication. The main goal is to see if the proced…
Phase: NA • Sponsor: SoniVie Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Heart stent showdown: which technique wins for left main blockages?
Disease control OngoingThis study compares two ways to place stents in the left main coronary artery when there is a blockage at the opening of a branch. One method places a stent only in the blocked branch, while the other extends a stent from the main artery into the branch. Researchers will track 10…
Sponsor: Istanbul Mehmet Akif Ersoy Educational and Training Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug BBD-1 shows promise for painful skin and kidney disease
Disease control ENROLLING_BY_INVITATIONThis study tests a new drug, BBD-1, against standard steroids for IgA vasculitis, a disease that causes purple spots on the skin, joint pain, and can damage the kidneys. The trial will enroll 30 adults with confirmed IgA vasculitis. The goal is to see if BBD-1 can clear skin spot…
Phase: PHASE2 • Sponsor: Qifeng Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for young brain tumor patients: chemotherapy first, then targeted radiation
Disease control OngoingThis clinical trial tests a risk-adapted approach for young children with newly diagnosed brain tumors. The treatment starts with chemotherapy to delay radiation, giving the brain more time to develop. Then, radiation is carefully targeted to the tumor area to reduce side effects…
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Tiny trial tests artificial vein valve for leg swelling
Disease control OngoingThis early study tests a new device called the Cook® Venous Valve System in just 4 people with chronic venous insufficiency (leg veins that don't pump blood back to the heart properly). The valve is implanted through a small tube into a deep leg vein to help blood flow one way. T…
Phase: NA • Sponsor: MED Institute Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Alzheimer's drug trial pulled before it even started
Disease control TerminatedThis study aimed to test a drug called BAC in people with Alzheimer's disease or vascular dementia. The goal was to see if it could improve thinking and memory, and to check for side effects. However, the trial was withdrawn before any participants were enrolled, so no results ar…
Phase: PHASE2 • Sponsor: Botanicure Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New study aims to boost cholesterol treatment in heart disease patients
Disease control ENROLLING_BY_INVITATIONThis study looks at different methods to help patients with high cholesterol and heart disease get the right medicines to lower their cholesterol. About 300 adults at high risk will take part. The goal is to see which approach helps more people reach their target LDL cholesterol …
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New clip device shows promise for leaky heart valve in Real-World study
Disease control OngoingThis study is tracking 511 patients with severe tricuspid regurgitation who are treated with the Abbott TriClip device in real-world settings. The main goal is to see if the device can successfully reduce the valve leak by at least one grade at discharge. Researchers are also mon…
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New imaging technique could improve stent outcomes in heart patients
Disease control OngoingThis study tests whether using a special imaging tool called OCT during stent placement leads to fewer heart problems over two years compared to standard methods. About 1,200 adults with blocked heart arteries that need complex stenting are taking part. The goal is to see if OCT …
Phase: NA • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Electric muscle training may tame high blood pressure without pills
Disease control OngoingThis study tests whether whole-body electromyostimulation (WB-EMS), a technology that stimulates muscles with mild electrical pulses, can lower resting blood pressure and improve other heart risk factors in overweight adults aged 50+ with mild hypertension. Over 12 weeks, 28 part…
Phase: NA • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Tiny heart, tiny device: new hope for premature babies
Disease control OngoingThis study tests a small device called the BLOOM Micro-Occluder to close a common heart hole (PDA) in premature babies. About 55 babies weighing between 600 and 2500 grams will be enrolled. The goal is to see if the device is safe and works well over 6 months.
Phase: NA • Sponsor: Merit Medical Systems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New pill may replace chemo for kids with brain tumors
Disease control OngoingThis study tests a new drug called DAY101 (tovorafenib) against standard chemotherapy for children and young adults with a type of brain tumor called low-grade glioma that has a specific gene change (RAF alteration). The goal is to see if the new drug works better at shrinking tu…
Phase: PHASE3 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Gut bacteria may be key to heart health, new study suggests
Disease control OngoingThis study tests whether a probiotic called Limosilactobacillus fermentum CRL 1446 can improve health in 80 adults with heart disease risk factors like obesity, high blood pressure, and high cholesterol. Participants take either the probiotic or a placebo daily, and researchers m…
Phase: NA • Sponsor: PINER Pastor Manfredi Winery • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Heart valve showdown: TAVI vs surgery in Mid-Risk patients
Disease control OngoingThis study compares two ways to replace a narrowed heart valve in people with severe aortic stenosis who are at intermediate risk for surgery. About 1,400 participants will be randomly assigned to get either a less invasive TAVI procedure or open-heart surgery (SAVR). The main go…
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
CRISPR therapy takes on rare swelling disorder
Disease control OngoingThis phase 3 trial tests a one-time gene editing treatment called NTLA-2002 for people with hereditary angioedema (HAE), a rare genetic condition causing sudden, painful swelling attacks. About 80 participants will receive either the treatment or a placebo. The goal is to see if …
Phase: PHASE3 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New monthly HAE shot tested for safety after switching from current meds
Disease control OngoingThis study looks at whether it is safe for people aged 12 and older with hereditary angioedema (HAE) to switch from their current preventive medicine to a new monthly injection called garadacimab. Researchers will monitor for side effects over about 3 months. The goal is to see i…
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New stent and shorter blood thinners could make heart treatment safer
Disease control OngoingThis phase 3 trial tests two things at once in 2312 people with coronary artery disease: a new drug-coated stent (Angiolite) versus a standard stent, and a shorter course of blood thinners versus the usual longer course. The goal is to see if the new stent works as well and if sh…
Phase: PHASE3 • Sponsor: iVascular S.L.U. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Free meals plus heart lessons may lower blood sugar and pressure in underserved communities
Disease control OngoingThis study tests whether adding culturally tailored heart-health education to medically tailored meal programs helps people with type 2 diabetes and high blood pressure eat better and improve their blood sugar and blood pressure. About 176 adults from low-income New York City nei…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart failure drug study pulled before it even started
Disease control TerminatedThis study was designed to test the safety and tolerability of a new drug called JK07 in people with heart failure and a specific type of high blood pressure in the lungs. It planned to enroll about 20 to 30 adults aged 18 to 85. However, the study was withdrawn before any partic…
Phase: PHASE2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New eye drop shows promise for glaucoma control in chinese patients
Disease control OngoingThis study tests a new eye drop called DE-117B in 345 Chinese adults with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure better than an existing drug. Participants use the drops once daily for at least 4 weeks, with long-term follow-…
Phase: PHASE3 • Sponsor: Santen Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can automated home BP checks and advice improve hypertension control?
Disease control ENROLLING_BY_INVITATIONThis study looks at whether automatically sending home blood pressure readings to doctors and getting automated advice through a patient portal can help people with high blood pressure lower their numbers better than just writing them down. About 1,300 adults with uncontrolled hy…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New Stent-Grafts aim to fix dangerous aortic bulges without major surgery
Disease control ENROLLING_BY_INVITATIONThis study looks at how well new, custom-made and off-the-shelf stent-grafts work for repairing complex aortic aneurysms (bulges in the main artery). About 750 people with aneurysms in the abdomen, chest, or arch will be treated using a less invasive procedure through blood vesse…
Phase: NA • Sponsor: Carlos Timaran • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart valve study pulled before it even started
Disease control TerminatedThis study planned to test a new device called the Cardiovalve for people with severe tricuspid regurgitation (a leaky heart valve). The goal was to see if the device could safely replace the valve and reduce leakage. However, the study was withdrawn before any participants were …
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New bypass device tested in Real-World leg artery study
Disease control ENROLLING_BY_INVITATIONThis study is following 450 people with long blockages in their leg arteries who are treated with the DETOUR System, a device that creates a bypass inside the artery. The goal is to see how well it works and how safe it is in everyday medical practice. Participants are chosen by …
Sponsor: Endologix • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New study weighs risks of treating vs. watching heart defect in preemies
Disease control OngoingThis study looks at whether actively treating a heart condition called patent ductus arteriosus (PDA) in premature babies is better than simply monitoring it. About 482 infants born between 22 and 28 weeks of pregnancy will be followed to see which approach reduces the risk of de…
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug could simplify treatment for rare EGPA disease
Disease control OngoingThis study tests whether a newer drug, benralizumab, works as well as the current standard, mepolizumab, for people with a rare disease called EGPA that inflames blood vessels. About 140 adults with active EGPA will receive either drug for a year, along with their usual steroids.…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Arm cuff before surgery may shield heart, trial suggests
Disease control OngoingThis study tests whether briefly inflating a blood-pressure cuff on the arm before non-cardiac surgery can reduce heart damage in high-risk patients. Over 1,200 participants will receive either the cuff procedure or no intervention. The goal is to see if this simple, low-cost tec…
Phase: NA • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Free quit-smoking support for heart patients could save lives and money
Disease control OngoingThis study tests whether a nurse-led smoking cessation program with free drugs and follow-up at healthy life centers helps heart patients quit smoking better than just giving them written information. About 221 daily smokers hospitalized for a heart event will be split into two g…
Phase: NA • Sponsor: Vestre Viken Hospital Trust • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New community health program targets diabetes and hypertension in underserved areas
Disease control OngoingThis study tests a community-based program to help Black and Latino adults with diabetes, prediabetes, high blood pressure, or obesity. Participants receive lifestyle coaching, help connecting to health and social services, and digital skills training. The goal is to see if this …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New valve offers hope for leaky heart condition
Disease control OngoingThis study tests a new device called the Cardiovalve TR system for people with a leaky tricuspid heart valve (tricuspid regurgitation). The goal is to see if the device is safe and can reduce the leak. The study involves 157 participants with moderate to severe symptoms. Research…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study: less invasive heart valve procedure as safe as surgery for Low-Risk patients
Disease control OngoingThis study tests whether a less invasive procedure called TAVR (replacing the aortic valve through a tube in an artery) is as safe and effective as open-heart surgery for people with severe aortic stenosis who are otherwise healthy enough for surgery. About 2,200 participants wil…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Smartphone app aims to land blood pressure safely
Disease control OngoingThis study tests a mobile health system called mGlide that helps patients with uncontrolled high blood pressure monitor their BP at home and automatically share readings with their healthcare team. The system alerts doctors when BP goes off track, allowing for timely medication a…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New heart stent technique aims to reduce repeat surgeries
Disease control OngoingThis study tests a new stenting technique called double kissing nano-culotte for people with complex blockages in heart arteries. The procedure uses two stents with minimal overlap to keep arteries open. Researchers will track 12 patients for heart attacks, repeat procedures, or …
Sponsor: Istanbul Mehmet Akif Ersoy Educational and Training Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for rare cancer: virus-based therapy combined with immunotherapy
Disease control OngoingThis study tests a new treatment for angiosarcoma, a rare and aggressive cancer of the blood vessels. The treatment combines a virus that is injected directly into tumors (vusolimogene oderparepvec) with an immunotherapy drug (pembrolizumab). The goal is to see if this combinatio…
Phase: PHASE2 • Sponsor: Varun Monga, MBBS • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New eye drop aims to lower glaucoma pressure
Disease control OngoingThis Phase 2 trial tests an experimental eye drop called BL1107 against a standard treatment (timolol) in 252 adults with glaucoma or high eye pressure. Participants use the drops twice daily for 28 days. The study measures changes in vision and eye pressure to see if BL1107 is s…
Phase: PHASE2 • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Study aims to find best treatment for leaky heart valve in older adults
Disease control ENROLLING_BY_INVITATIONThis study looks at 3,500 people with severe tricuspid regurgitation, a common heart valve problem in older adults. It compares medical therapy (diuretics), surgery, and a less invasive transcatheter procedure to see which works best and when to treat. The goal is to improve surv…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New sensor could spot hidden heart attacks in minutes
Diagnosis TerminatedThis study tests a device called Infrasensor that may help doctors quickly identify people with severe heart artery blockages. About 350 adults with chest pain will use the device for 5 minutes, and results will be compared to standard heart catheterization. If accurate, it could…
Sponsor: Remote Cardiac Enablement • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New heart scan method could catch hidden lung pressure earlier
Diagnosis OngoingThis study looks at whether a new computer program called IMPULSE can better detect pulmonary hypertension (high blood pressure in the lungs) using standard heart ultrasound. About 200 adults with unexplained breathlessness or risk factors will be checked. The goal is to see if t…
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Smart scale showdown: withings takes on apple watch for blood pressure detection
Diagnosis OngoingThis study checks if a Withings smart scale can accurately spot signs of high blood pressure by looking at body measurements like weight and heart rate. Researchers compared the scale's results to a standard blood pressure cuff in 2,500 adults. The goal is to see if the scale wor…
Sponsor: Withings • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Brain scans track Alzheimer's clues over decades
Diagnosis ENROLLING_BY_INVITATIONThis study uses special brain scans (PET imaging) to measure amyloid buildup—a protein linked to Alzheimer's—in healthy older adults, people with mild memory problems, and those with dementia. Participants receive scans every 2-3 years for up to 20 years to see how amyloid change…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
AI eye on brain bulges: software aims to spot hidden aneurysms
Diagnosis OngoingThis study evaluates RDX-Aneurysm, a computer-assisted detection software designed to help radiologists find saccular intracranial aneurysms (bulging blood vessels in the brain) on MRI scans. Researchers will analyze 550 past scans—half with confirmed aneurysms and half without—t…
Sponsor: Taipei Medical University Shuang Ho Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Hidden cancer hunt: Full-Body scan could spot tumors in blood clot patients
Diagnosis OngoingThis study looks at whether a detailed full-body scan called FDG PET/CT can find hidden cancers in people aged 50 and older who have had an unexplained blood clot. About 1,276 participants will get either the scan or standard cancer checks. The goal is to see if the scan catches …
Phase: NA • Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New baby blood pressure monitor could save tiny lives
Diagnosis ENROLLING_BY_INVITATIONThis study tests a new, gentle device called Boppli that continuously measures blood pressure in newborn babies in the NICU. Researchers will compare it to the standard blood pressure cuff to see if it works better at finding high blood pressure. The study includes 30 infants at …
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
AI eye test spots silent artery disease before it strikes
Diagnosis OngoingThis study is developing an artificial intelligence tool that can detect hidden plaque in arteries by analyzing photos of the retina (the back of the eye). About 884 adults without known heart disease will have eye photos taken and compared with ultrasound scans of their neck and…
Sponsor: Infanta Leonor University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New laser imaging could help surgeons prevent strokes during brain surgery
Diagnosis TerminatedThis study tests a laser-based imaging method that shows blood flow in the brain in real time during surgery. It involves 20 adults having brain surgery for conditions like aneurysms. The goal is to see if this technique can give surgeons continuous feedback, unlike the current d…
Sponsor: Andrew Dunn • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Blood test may replace invasive heart scans
Diagnosis OngoingThis study looks at whether certain blood markers can identify people without significant coronary artery disease, avoiding the need for more invasive tests. Researchers will enroll 1000 adults referred for a CT scan of the heart. The goal is to see if these biomarkers can accura…
Sponsor: University Hospital, Akershus • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Simple urine test could spot dangerous pregnancy condition early
Diagnosis OngoingThis study tests a new urine test called CercaTest™ Red to predict preeclampsia in pregnant women who show signs of the condition. Preeclampsia is a serious complication involving high blood pressure and organ damage. The test is designed to be used at the point of care, giving q…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
AI heart scan trial aims to sharpen diagnosis of clogged arteries
Diagnosis OngoingThis study compares a new AI-based method of analyzing CT scans of the heart to standard care for people with symptoms that might be coronary artery disease. The goal is to see if the AI approach helps doctors diagnose the condition more accurately, control risk factors like chol…
Phase: NA • Sponsor: Cleerly, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
New trial aims to solve long COVID chest pain mystery
Diagnosis OngoingThis study looks at people with Long COVID who have new chest pain but no blocked arteries. It tests whether a special heart function test can guide treatment to improve symptoms and quality of life. 108 participants will be randomly assigned to either treatment guided by the tes…
Phase: NA • Sponsor: Fundacion Investigacion Interhospitalaria Cardiovascular • Aim: Diagnosis
Last updated Jun 27, 2026 12:39 UTC
-
Heart scan clues may predict future attacks
Diagnosis OngoingThis study looks at CT scans of the heart from 22,000 people who had chest pain. Researchers want to see if certain features of plaque (fatty deposits) in the heart arteries can help predict who will later have a heart attack, stroke, or die from heart disease. The goal is to imp…
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Can a smart patch outsmart hidden heart risks after stroke?
Diagnosis OngoingThis study looks at better ways to find hidden atrial fibrillation (an irregular heartbeat) in people who have had a stroke. About 337 participants will use either a wearable patch for 72 hours or a handheld device three times a day to monitor their heart rhythm. The goal is to s…
Phase: NA • Sponsor: Ewha Womans University Mokdong Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Smart blood pressure cuff could spot hidden heart rhythm problem
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether a special home blood pressure monitor that can detect atrial fibrillation (AFib) helps diagnose the condition faster in older adults with high blood pressure. About 1,900 participants aged 60 and older will take daily blood pressure readings and answ…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
AI reads heart scans to predict heart attacks
Diagnosis ENROLLING_BY_INVITATIONThis study is developing an artificial intelligence system to analyze CT scans of the heart. The goal is to automatically detect and measure dangerous plaque that can cause heart attacks. Researchers will compare the AI's findings with detailed imaging tests and track patient out…
Sponsor: Jinling Hospital, China • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New heart scan method could spot hidden blockages
Diagnosis OngoingThis study looks at two new methods to tell apart blockages in large versus tiny heart arteries. About 68 adults with known or suspected coronary artery disease will get a PET scan and a heart catheterization. Researchers will compare the new measurements with standard tests to s…
Sponsor: University of Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Beats over blood pressure: music campaign aims to prevent stroke in nigeria
Prevention OngoingThis study tests whether a music-inspired community campaign, called Music4Health, can help lower blood pressure and improve stroke awareness among 1,412 youth (ages 14-24) and their caregivers (ages 40+) in Nigeria. Participants will take part in listening sessions and activitie…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Cleaner cookstoves may lower blood pressure in nigerian communities
Prevention OngoingThis study looks at whether helping communities switch to cleaner cookstoves can lower indoor air pollution and prevent high blood pressure. About 1,280 households in Nigeria will take part. Some families get extra support to use the new stoves, while others just receive informat…
Phase: NA • Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Can virtual doula sessions and home monitoring prevent preeclampsia in black women?
Prevention ENROLLING_BY_INVITATIONThis study will test a telehealth group prenatal care program called Centering HER in 72 low-income, predominantly Black pregnant women in Kansas who are at moderate or high risk for preeclampsia. Participants will receive routine care plus seven doula-led virtual group sessions,…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Cheap pill could save millions from blindness, major trial launches
Prevention OngoingThis study tests whether fenofibrate, a drug already used for high cholesterol, can prevent diabetic retinopathy from worsening in people with mild to moderate disease. About 560 adults with diabetes will take either fenofibrate or a placebo for up to 6 years. The goal is to see …
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Heart health hope: new program targets high blood pressure in orange county families
Prevention OngoingThis study tests whether a culturally tailored, skills-based program delivered by community health workers can help Latinx and Vietnamese families in Santa Ana, CA, improve their heart health and prevent high blood pressure. About 483 participants will receive either the special …
Phase: NA • Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Heart scan strategy aims to slash cardiac events in rural china
Prevention ENROLLING_BY_INVITATIONThis study tests whether using a special heart CT scan to guide intensive treatment can reduce major heart problems like heart attacks and strokes compared to standard care. About 15,000 high-risk adults aged 40-75 in rural China will take part. The goal is to see if this persona…
Phase: NA • Sponsor: Harbin Medical University • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Twice-Yearly shot could prevent heart attacks in millions
Prevention OngoingThis large Phase 3 study tests whether inclisiran, a twice-yearly injection, can prevent major heart problems like heart attacks, strokes, and heart-related death in people at high risk who have not yet had such an event. Over 14,000 participants are receiving either inclisiran o…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Phone apps may cut heart risk after pregnancy blood pressure problems
Prevention OngoingThis study tests whether using a smartphone app and a home blood pressure monitor can help prevent heart disease in women who had high blood pressure during pregnancy. 120 women who gave birth at Northwestern Memorial Hospital will use these digital tools for 12 months after deli…
Phase: NA • Sponsor: Northwestern University • Aim: Prevention
Last updated Jun 27, 2026 13:05 UTC
-
North carolina launches massive effort to protect pregnant women from hypertension
Prevention ENROLLING_BY_INVITATIONThis study tests a community-based program called Thriving Hearts across ten North Carolina counties. Pregnant individuals at risk for hypertensive disorders receive a care kit with a home blood pressure monitor and stress management tools, plus extra support from healthcare prov…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jun 27, 2026 13:05 UTC
-
Free meals and coaching aim to cut pregnancy risks
Prevention OngoingThis study tests whether providing fresh meals, health coaching, and education to high-risk pregnant women can reduce the chance of developing gestational diabetes, high blood pressure, or preeclampsia. 69 women in Milwaukee are randomly assigned to either receive the program or …
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New daily pill could stop menstrual migraines before they start
Prevention OngoingThis study tests a new medicine called atogepant to prevent migraines that happen around a woman's period. About 430 adult women with regular cycles and a history of migraines will take either atogepant or a placebo daily for 3 menstrual cycles. The goal is to see if the drug red…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Spinal zaps may help vets with paralysis boost blood pressure and exercise
Symptom relief OngoingThis study tests whether a non-invasive electrical stimulation device placed on the skin over the spine can help veterans with spinal cord injury improve blood pressure, exercise capacity, and body temperature regulation. Twenty veterans with injuries between the neck and upper b…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Which exercise works best for stroke survivors with knee hyperextension?
Symptom relief ENROLLING_BY_INVITATIONThis study compares two types of exercise—open kinetic chain (like leg raises) and closed kinetic chain (like squats)—to see which better reduces knee hyperextension in stroke survivors. Sixty adults who have had a stroke and can walk with some help will be randomly assigned to o…
Phase: NA • Sponsor: Dow University of Health Sciences • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Tighter stockings after vein surgery: do they really help more?
Symptom relief OngoingThis trial tests whether wearing compression stockings with a higher (32 mmHg) or lower (21 mmHg) pressure after radiofrequency ablation for varicose veins leads to less pain and swelling. About 64 adults with varicose veins and leg swelling will wear one of the two stocking type…
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Book club therapy: could group reading boost language skills after stroke?
Symptom relief OngoingThis study explores whether joining a weekly reading group can improve reading comprehension and communication confidence in adults with aphasia, a language disorder often caused by stroke. Participants read a book at home and then discuss it in a 90-minute group session each wee…
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Pole power: new walking workout could supercharge heart recovery
Symptom relief OngoingThis study tests a new exercise program for people with coronary artery disease who have had heart surgery or a stent. The program combines high-intensity interval training with Nordic walking (walking with poles). Researchers want to see if it is safe, enjoyable, and better at i…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Quick brain zaps could boost thinking after stroke
Symptom relief OngoingThis study tests a short, high-dose form of brain stimulation called repetitive transcranial magnetic stimulation (rTMS) in 20 people who had a stroke at least 6 months ago. The goal is to see if it is safe and acceptable, and whether it can improve cognitive problems like memory…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Warm water workouts may boost arm strength and independence in kids with cerebral palsy
Symptom relief OngoingThis study looks at whether aquatic therapy in a warm pool can help children ages 3-9 with conditions like cerebral palsy improve their swimming safety, arm function, and ability to do daily tasks. Children attend sessions twice a week for ten weeks. Researchers will measure chan…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New injection aims to ease stroke-related muscle stiffness
Symptom relief OngoingThis study tests whether an injection of hyaluronidase can reduce muscle stiffness and spasticity in the arm after a stroke. 56 adults with moderate-to-severe stiffness will receive either the study drug or a placebo, and later switch to the other option. The goal is to improve r…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can yoga ease severe headaches? small pilot study aims to find out
Symptom relief OngoingThis pilot study is testing whether yoga-based movements, done online or in person, can help people with chronic migraine or cluster headache. Twenty adults aged 18-65 will participate. The goal is to see if yoga improves headache frequency, sleep quality, and overall well-being …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a daily migraine pill stop attacks fast? new trial aims to find out
Symptom relief OngoingThis study tests whether atogepant, a drug already used to prevent migraines, can also treat migraine attacks quickly. About 1300 adults with a history of migraines will take either atogepant or a placebo when they have a migraine, and then report pain levels and symptoms after 2…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
WhatsApp therapy could boost stroke hand recovery
Symptom relief OngoingThis study tests whether adding home-based telerehabilitation via WhatsApp video calls to standard outpatient therapy improves hand function in people who had a stroke 1-6 months ago. Forty-eight participants will be split into two groups: one gets standard therapy plus daily 30-…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Phone app aims to cut high blood pressure in black men
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a smartphone-based stress management program can help Black men with hypertension lower their blood pressure and feel less stressed. About 135 participants will either use a culturally tailored app (m-CBSMi) or take a standard online stress course. Resear…
Phase: PHASE2 • Sponsor: ISA Associates, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New nerve block combo may cut opioid use after heart surgery
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether adding two ultrasound-guided nerve blocks to standard pain relief can lower opioid use and pain after coronary artery bypass grafting. 88 adults having elective bypass surgery will be randomly assigned to receive either the nerve blocks plus standard medi…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can specialized walking drills help stroke survivors regain balance?
Symptom relief OngoingThis study tests two different movement training methods—sprinter-style and skater-style—to see which better improves balance and coordination in people who had a stroke at least six months ago. Twenty-two participants will do 30-minute sessions three times a week for four weeks.…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can extra salt stop seniors from falling? new trial investigates
Symptom relief OngoingThis study tests whether taking extra salt (5 grams per day in capsules) can improve symptoms and quality of life in older adults (65+) who experience dizziness and falls due to orthostatic hypotension. The trial involves 42 participants and lasts 12 months, focusing on whether s…
Phase: PHASE2 • Sponsor: University of Galway • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Mindfulness may soothe heart Patients' anxiety
Symptom relief OngoingThis study tests whether an 8-week mindfulness meditation program (MBSR) can reduce anxiety and depression in heart patients who have completed cardiac rehab. About 74 participants will either take the meditation course or continue with standard rehab. Researchers will measure ch…
Phase: NA • Sponsor: Elsan • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Sound waves to the calf could help you walk farther without pain
Symptom relief OngoingThis study tests whether applying shockwave therapy to the calf muscles can improve blood flow and reduce pain in people with peripheral artery disease. About 138 adults with stable leg pain when walking will receive the treatment. The goal is to see if it helps them walk longer …
Phase: NA • Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Nerve zapper offers hope for chronic headache sufferers
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a 60-day nerve stimulation device placed near the back of the head can help people with stubborn headaches. Researchers will track pain levels, daily function, and how often participants need emergency care. About 300 adults with various headache types…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Mindfulness may ease emotional struggles after stroke
Symptom relief OngoingThis study looks at whether an 8-week mindfulness course can help people who had a stroke at least 6 months ago. About 28 participants will take the course either right away or after a wait. The goal is to see if the course is practical and if it improves emotional well-being and…
Phase: NA • Sponsor: HealthPartners Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New pill could stop dangerous swelling attacks in hereditary angioedema
Symptom relief ENROLLING_BY_INVITATIONThis study tests a pill called deucrictibant for quickly treating swelling attacks in people with hereditary angioedema (HAE), including life-threatening throat swelling. About 150 adults who have had HAE attacks before will take the drug as needed and be monitored for safety and…
Phase: PHASE2, PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can tape and exercise ease tired, aching legs? new study tests simple fixes for vein issues
Symptom relief OngoingThis study tests whether kinesio taping (a special elastic tape) and interval exercise (short bursts of activity) can help people with mild chronic venous insufficiency feel better and improve their quality of life. About 33 adults aged 18 to 65 will be split into three groups: o…
Phase: NA • Sponsor: Necmettin Erbakan University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can walking with a buddy help women with HIV and hypertension?
Symptom relief OngoingThis study looks at whether a program that combines physical activity with support from a peer is acceptable and practical for women living with both HIV and high blood pressure. About 50 women aged 40 and older will take part. The goal is to see if women stick with the program a…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
VR goggles could replace sedation for vein surgery patients
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether wearing a virtual reality headset during laser treatment for varicose veins can lower anxiety and pain. About 100 adults will use VR during the procedure, and researchers will measure their heart rate, blood pressure, and comfort levels. The goal is to se…
Phase: NA • Sponsor: Bydgoszcz University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Easy exercises may ease stress and improve sleep in High-Risk pregnancies
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether progressive muscle relaxation and finger grip exercises can lower stress, anxiety, and fatigue while improving sleep in pregnant women with preeclampsia. About 90 women will be split into three groups: one doing relaxation exercises, one doing finger g…
Phase: NA • Sponsor: Hatice Nur Nefes Pala • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Shining a light on PAD: simple home therapy could ease walking pain
Symptom relief OngoingThis study tests whether using a far red light device on the legs for 10 minutes twice a day can improve walking distance in people with peripheral artery disease (PAD). The trial involves 32 adults aged 50 and older with PAD. Participants use the light at home for four months, a…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Which arm therapy works best after stroke? new trial aims to find out
Symptom relief OngoingThis study compares two types of hand and arm therapy for people who had a stroke 3 to 6 months ago. One therapy involves restraining the good arm to force use of the affected arm, while the other focuses on using both arms together. Both groups also receive standard physical the…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Air cuffs boost walking in blocked leg arteries?
Symptom relief OngoingThis study tests whether wearing inflatable leg cuffs (intermittent pneumatic compression) for six months can improve walking distance in people with peripheral artery disease (PAD). Some participants also combine the cuffs with walking exercise. The goal is to see if the cuffs h…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Shock or shake? study tests two methods to restore leg function after stroke
Symptom relief OngoingThis study compares two treatments—Functional Electrical Stimulation (FES) and Whole Body Vibration Training (WBVT)—to see which better improves leg control, balance, and daily activities in people who had a stroke 6 months to 1 year ago. Thirty-four adults aged 35 to 70 will rec…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New study tests which therapy helps stroke survivors regain arm movement faster
Symptom relief ENROLLING_BY_INVITATIONThis study compares two physical therapy approaches—Rood's techniques (using touch, stretch, and ice) and PNF patterns (diagonal movements)—to improve arm and hand function in people who recently had a stroke. 28 adults aged 40-60 with a first-time stroke will receive one of the …
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Which Pre-Surgery drug calms nerves and eases pain best?
Symptom relief OngoingThis study tests two medications, dexmedetomidine and tramadol, given before hemorrhoid surgery to see which one better reduces anxiety and pain. Ninety adults will receive one of the drugs or a placebo before spinal anesthesia. Researchers will measure anxiety levels and pain sc…
Phase: NA • Sponsor: Yuzuncu Yil University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Gout drug allopurinol may boost heart function in african americans with resistant hypertension
Symptom relief OngoingThis study tests whether allopurinol, a common gout medication, can improve heart function in African American veterans with resistant hypertension. Participants take allopurinol for 8 weeks, and researchers measure changes in heart function, exercise ability, and quality of life…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
VR headsets aim to ease stress and heart risks in black women
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a virtual reality (VR) wellness program can help Black women with high blood pressure reduce stress and improve heart health. Sixty Black women in South Florida will either use a five-week VR program or receive standard educational materials. Researchers …
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New study tests which therapy helps stroke survivors regain core strength faster
Symptom relief ENROLLING_BY_INVITATIONThis study compares two physical therapy techniques—PNF and NDT—to see which better helps stroke survivors improve trunk control and balance. It will involve 32 people aged 40-65 who have had a recent stroke. Participants will receive electrical stimulation plus one of the two th…
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can a 6-Week prep program help patients before aortic aneurysm surgery?
Symptom relief OngoingThis trial tests a 6-week program called Ready for Recovery that helps people prepare for aortic aneurysm surgery. The program includes education, healthy habits, stress reduction, and social support. Ten adults having elective surgery will participate to see if the program is fe…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New surgical technique aims to ease hemorrhoid pain
Symptom relief OngoingThis study tests whether using argon plasma coagulation during hemorrhoid surgery can reduce pain and complications compared to standard methods. About 100 adults with severe hemorrhoids will be randomly assigned to one of two surgical techniques. Pain levels and recovery will be…
Phase: NA • Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New arm brace could help stroke survivors regain movement
Symptom relief OngoingThis study tests whether a special arm brace that reads muscle signals can help stroke survivors with severe arm weakness recover better during early rehabilitation. Three veterans who had a stroke within the past 6 months will use the device alongside standard therapy. The goal …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Heart rehab gets personal: new program targets Women's sexual Well-Being
Symptom relief OngoingThis study tests a nurse-led education program designed to help women in cardiac rehab address sexual concerns after a heart event. Sixty-six women will be randomly assigned to either the program or usual care. The goal is to see if the program improves sexual function, mood, and…
Phase: NA • Sponsor: Hospital Universitario Virgen Macarena • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New hope for migraine sufferers: drug works when others fail
Symptom relief OngoingThis study tests whether eptinezumab can reduce migraine days and improve quality of life in 164 adults who previously did not get enough relief from other CGRP-targeting migraine drugs. Participants receive the drug and report changes in migraine frequency and severity over time…
Phase: PHASE4 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Parents and therapists team up to boost walking in kids with stroke
Symptom relief OngoingThis study tests whether early, intensive leg exercises, done by a physical therapist and a parent together, can improve walking and motor skills in children aged 8 months to 3 years who had a stroke around birth. The study compares this approach to usual care. The goal is to see…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can touch or mirror tricks restore arm movement after stroke?
Symptom relief OngoingThis study compares two rehabilitation methods—somatosensory stimulation (using touch) and task-based mirror therapy (using a mirror to trick the brain)—to see which better improves arm and hand function in stroke survivors. About 24 adults who had a stroke 1 to 6 months ago will…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy aims to restore arm movement after stroke
Symptom relief OngoingThis study tests whether combining gentle touch stimulation with nerve exercises can improve arm movement and feeling in people who had a stroke 6-12 months ago. 53 adults aged 45-65 with lasting arm weakness and sensory loss are participating. The goal is to see if this therapy …
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Which workout helps stroke survivors walk better? new study compares two rehab programs.
Symptom relief OngoingThis study compares two types of exercise programs to see which one better improves balance and leg movement in people who have had a stroke. The study includes 52 adults aged 45 to 65 who had a stroke 6 to 10 months ago and have mild to moderate leg weakness. Participants will d…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Nerve zapping eases migraine pain in new study
Symptom relief OngoingThis study looks at whether a treatment called pulsed radiofrequency (PRF) on a nerve at the back of the head can help people with migraines. Researchers measured pain sensitivity and disability in 100 adults before and up to 3 months after the procedure. The goal is to see if th…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Smaller incision, faster recovery? new trial tests heart bypass techniques
Symptom relief OngoingThis study compares two types of heart bypass surgery for people with blocked arteries: a minimally invasive approach using small incisions between the ribs versus the traditional method that opens the breastbone. Researchers want to see if the less invasive surgery leads to bett…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a wrist vibration gadget restore hand control after a stroke?
Symptom relief TerminatedThis study tests a small, wearable device that gives gentle vibrations to the wrist of stroke survivors. The goal is to see if it's practical for people to use at home and whether it might improve hand movement and feeling. Only 20 people who had a stroke at least six months ago …
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Talking your way to a healthier heart: new study tests simple exercise guide
Knowledge-focused OngoingThis pilot study tests whether a simple 'Talk Test' can safely and effectively prescribe exercise for heart patients recovering at home after bypass surgery or stent placement. Forty participants will be randomly assigned to get exercise instructions based on either the Talk Test…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
AI takes on blood clotting: can ChatGPT guide surgeons on bleeding?
Knowledge-focused TerminatedThis study evaluates whether artificial intelligence models can accurately interpret ROTEM blood clotting tests and recommend treatments for coagulopathy. Researchers will compare AI decisions to those of a panel of clinical experts using data from adults undergoing elective card…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Blood test may predict aneurysm surgery need in marfan patients
Knowledge-focused OngoingThis study looks for biological markers in the blood and tissue of adults with Marfan syndrome that could signal when an aortic aneurysm is dangerous enough to require surgery. Researchers will compare three groups of Marfan patients: those without aortic aneurysms, those with st…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Hidden pelvic vein issues may sabotage leg vein surgery, study warns
Knowledge-focused OngoingThis study looks at how often pelvic congestion syndrome (a condition where veins in the pelvis become enlarged and painful) occurs in women who are about to have a standard procedure for leg varicose veins. Researchers want to know if having this pelvic condition affects how muc…
Sponsor: Chengdu University of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Brain scans after stroke may unlock secrets of cognitive decline
Knowledge-focused OngoingThis study follows 250 people who had a type of stroke called intracerebral hemorrhage (ICH) to understand why some experience progressive cognitive decline. Participants undergo advanced brain scans and tests of thinking and movement at 12–24 months after their stroke, with foll…
Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Heart-Lung connection under the knife: new study probes ventilator settings
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how different levels of pressure from a breathing machine (called PEEP) affect the heart's pumping ability in 28 adults having heart surgery. Doctors will use special imaging and monitors to measure heart function at four different pressure settings. The goal …
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Massive baltimore study tracks how race and wealth shape aging
Knowledge-focused OngoingThis long-term study follows over 3,700 adults in Baltimore to understand why some people age healthier than others. Researchers are looking at how race, income, and neighborhood affect risks for diseases like diabetes, heart disease, and memory loss. Participants visit mobile he…
Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Blood test may flag heart danger before carotid surgery
Knowledge-focused OngoingThis trial investigates whether measuring high-sensitive troponin, a protein released during heart injury, can predict heart complications in people undergoing surgery to open a narrowed carotid artery. About 527 participants will have their troponin levels checked before and aft…
Sponsor: University of Belgrade • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Thousands tracked after heart stent procedure in major chinese study
Knowledge-focused OngoingThis study follows 2,000 people in China who received the SYNERGY stent to open blocked heart arteries. Researchers are collecting real-world data on safety and major heart events after the procedure. The goal is to see how well the stent performs in everyday medical practice.
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
AI avatar vs. human doctor: which do SCAD patients trust more?
Knowledge-focused ENROLLING_BY_INVITATIONThis pilot study at Mayo Clinic will test whether people with spontaneous coronary artery dissection (SCAD) feel more comfortable talking to an AI avatar or a human clinician before their appointment. About 150 patients will interact with the avatar and then rate their satisfacti…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Real-World check: does aflibercept 8 mg hold up outside the lab?
Knowledge-focused OngoingThis observational study will follow 2,500 adults with vision loss from nAMD or DME who are already prescribed aflibercept 8 mg by their doctors. Researchers will collect data from routine visits over up to 24 months to see how vision changes. The goal is to understand how well t…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Marathoners' hearts under the microscope: is that plaque dangerous?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 250 male endurance athletes who were part of an earlier study to see how their heart arteries have changed over time. Researchers will use CT scans and AI to examine plaque buildup and determine if it is stable and harmless or likely to cause heart attacks. The…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Blood samples sought to unlock secrets of sickle cell disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and other samples from people with sickle cell disease and healthy volunteers to help researchers understand how inflammation affects blood vessels. Up to 2,000 adults aged 18 and older will take part. The samples will be used in lab tests to support fut…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New Light-Based sensors could spot hidden heart defects in newborns
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether combining standard monitoring tools with new light-based sensors can better detect a dangerous narrowing of the aorta in newborns. Infants under one month old with suspected aortic arch obstruction will be monitored using resonance Raman spectroscopy, pul…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists track varicose veins from start to worse
Knowledge-focused OngoingThis study follows 100 people with and without varicose veins to see how often the condition appears and how it changes over time. Participants get yearly checkups including ultrasound exams. The goal is to learn what factors make vein disease worse and how it naturally progresse…
Sponsor: Russian Phlebological Association • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Massive korean study maps the overlap of heart, kidney, and metabolic diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study examines health data from about 800,000 Korean adults to see how often conditions like obesity, type 2 diabetes, heart disease, chronic kidney disease, and fatty liver occur together. Researchers will analyze national survey and insurance records from 2013 to 2023. No …
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Simple tweak to doctor's computer screen may improve blood pressure treatment for thousands
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether changing how combination blood pressure pills appear in the electronic health record can encourage doctors to prescribe them more often. Over 12,000 patients will be included, and researchers will track whether a simple label like "(PREFERRED)" makes a di…
Phase: NA • Sponsor: Geisinger Clinic • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New registry aims to unlock mysteries of Pregnancy-Related aortic tears
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a national registry in China that will track 500 women who experience an aortic dissection (a tear in the main artery) during pregnancy or within 12 weeks after giving birth. Researchers will collect information on treatments and outcomes for both mothers and babies…
Sponsor: DeltaHealth Hospital · Shanghai • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Can a tablet and home monitors help you manage diabetes and high blood pressure?
Knowledge-focused ENROLLING_BY_INVITATIONThis study compares two ways of delivering a health and wellness program to people with chronic conditions like diabetes and high blood pressure. One group gets a kit with a tablet and home monitors for blood pressure and blood sugar; the other gets standard phone calls. The goal…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Could a blood pressure drug ease chest pain in people with clear arteries?
Knowledge-focused OngoingThis study looks at whether bosentan, a drug that blocks a natural vessel-constricting substance, can improve blood flow in the tiny heart vessels of people with angina who have no major blockages. About 45 participants will get bosentan for 4 weeks and have MRI scans before and …
Phase: NA • Sponsor: Liverpool University Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
AI-Powered text messages aim to tame high blood pressure in 12,000 patients
Knowledge-focused OngoingThis study looks at whether personalized digital messages can help 12,000 adults with uncontrolled high blood pressure stick to their treatment plan. The messages are tailored using artificial intelligence to encourage doctor visits, medication adherence, and home blood pressure …
Sponsor: Lirio • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Hidden costs of caregiving: new study tracks financial toxicity in cirrhosis families
Knowledge-focused OngoingThis observational study looks at the financial and social challenges faced by informal caregivers of people with cirrhosis. Researchers will measure out-of-pocket costs, lost work time, and financial distress using surveys. The goal is to understand how these burdens affect care…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Brain procedure may weaken immune defenses, study warns
Knowledge-focused OngoingThis study looks at how a brain procedure called embolization affects the immune system. Researchers will take blood samples from 78 patients before and after the procedure to measure immune markers. They want to understand why patients with brain arteriovenous malformations (AVM…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Heart stent recovery: does better Follow-Up care lead to healthier lives?
Knowledge-focused OngoingThis study follows over 3,400 adults who have had a heart stent procedure to understand how continuity of care, health literacy, and medication adherence influence their long-term health. Researchers will track hospital readmissions, medication use, and patient-reported outcomes …
Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Arctic work and heart risk: new study probes hidden dangers
Knowledge-focused OngoingThis study looks at how high blood pressure changes the heart's structure in people who work rotating shifts in the Arctic. Researchers will track 550 workers over a year using heart ultrasounds and blood tests. The goal is to understand why some develop heart failure, not to tes…
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Heart gene bank launched: 9,880 patients enrolled to unlock secrets of coronary artery disease
Knowledge-focused OngoingThis study is building a large gene bank by collecting blood samples and health information from nearly 10,000 people who have had heart catheterization or cardiac CT scans. The goal is to identify genetic and other factors that contribute to coronary artery disease. Participants…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Blood pressure during pancreatic surgery may predict recovery
Knowledge-focused ENROLLING_BY_INVITATIONThis study observes 60 adults undergoing open pancreatic surgery to see if low blood pressure during the operation is linked to higher lactate levels afterward. Lactate is a marker of how well tissues are getting oxygen. The goal is to find patterns that could help doctors adjust…
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can a quick ultrasound prevent dangerous blood pressure drops in hip surgery?
Knowledge-focused OngoingThis study looks at whether an ultrasound measurement of a large vein near the heart (the inferior vena cava) can predict when a patient's blood pressure will drop dangerously during hip replacement surgery. Researchers will measure this vein's flexibility before cement is used t…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can a One-Page guide spark better End-of-Life talks for dementia patients?
Knowledge-focused OngoingThis study tests a short guide called the 'Jumpstart Guide' to help doctors have better conversations with dementia patients and their families about healthcare goals. Over 1,800 patients and their caregivers are taking part. Researchers will compare whether those whose doctors u…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists Fine-Tune diagnostic tools for autonomic nervous system disorders
Knowledge-focused OngoingThis study aims to improve how doctors test for autonomic failure, a condition where the body's automatic functions like blood pressure control don't work properly. Researchers will use advanced imaging, sweat tests, and skin biopsies in up to 89 adults with Parkinson's disease, …
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Brain bleed trial blueprint: will it pave the way for new treatments?
Knowledge-focused OngoingThis study, called PLINTH, is a feasibility trial for adults who had a stroke from a brain hemorrhage. Researchers want to know if patients and doctors would accept a future platform trial, and how to design it to be inclusive and efficient. About 169 participants will watch an i…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New wearable device could replace blood tests during surgery recovery
Knowledge-focused OngoingThis study tests a wearable device that continuously measures lactate levels in the fluid just under the skin. Researchers want to see if it matches standard blood tests in patients recovering from heart bypass or valve surgery. If it works, the device could make recovery more co…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Massive 30-Year Women's health study reveals hidden disease links
Knowledge-focused OngoingThis long-running study follows nearly 100,000 French women, mostly teachers, since 1990 to understand what factors influence their risk of cancer, heart disease, diabetes, and other major illnesses. Participants fill out questionnaires every few years about their lifestyle, medi…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could a softer Heart-Lung machine protect the brain during surgery?
Knowledge-focused OngoingThis study tests whether a newer, less invasive heart-lung machine (MiECC) reduces brain swelling and stroke risk compared to the standard machine used during open heart surgery. Researchers will measure optic nerve sheath diameter (a marker of brain pressure) and track strokes o…
Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Blood thinner levels under microscope to prevent clots and bleeding
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study tracks 5,000 people taking common blood thinners (like rivaroxaban or apixaban) or antiplatelet drugs (like aspirin). Researchers regularly measure drug levels in the blood to see how they relate to clots or bleeding events. The goal is to find the best d…
Sponsor: The Third Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Stool sample may predict survival in ICU patients
Knowledge-focused OngoingThis study looks at whether measuring lactate in stool can help doctors predict how well critically ill patients with low blood flow will respond to treatment. About 40 adults in the ICU will provide a stool sample within 24 hours of admission. Researchers will check if high stoo…
Sponsor: Hospital H+ Queretaro • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Smartphone exercise app tested for seniors – but study pulled
Knowledge-focused TerminatedThis study aimed to see if a personalized exercise app (Gingko Active) could improve physical function in adults aged 45 and older better than a standard exercise booklet. The trial was withdrawn before any participants enrolled, so no results are available. The app was designed …
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can better doctor chat lower blood pressure? duke study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a training program that teaches doctors how to better talk with, listen to, and involve patients in their own care. About 180 doctors and their patients with high blood pressure will take part. The main goal is to see if the training is practical and acceptable, …
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Caffeine dosing study for newborns with HIE aims to improve safety
Knowledge-focused OngoingThis study looks at how caffeine is processed in newborns with hypoxic-ischemic encephalopathy (HIE), a brain injury caused by lack of oxygen, who are receiving cooling therapy. Researchers will test different doses of caffeine in 16 babies to find the safest and most effective a…
Phase: PHASE1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Forgotten side effect: new study tracks leg swelling in men with prostate cancer
Knowledge-focused OngoingThis study follows 214 men treated for prostate cancer to see how many develop lower limb lymphedema (leg swelling) and who is most at risk. Participants attend check-ups every three months for 18 months. The goal is to better understand this side effect and its impact on quality…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New scan method could prevent unnecessary stents after heart attacks
Knowledge-focused OngoingThis study looks at 90 people who recently had a heart attack and have other artery narrowings that may or may not be dangerous. Researchers will use two types of scans—optical coherence tomography (OCT) and magnetic resonance angiography (MRA)—to see if they can tell which narro…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New strategy aims to predict heart attacks before they happen
Knowledge-focused OngoingThis study tests a new way to find unstable plaques in the heart arteries of people who come to the emergency room with chest pain but are not having a heart attack. Researchers use a simple calcium scan to group patients by risk, then follow up with special PET scans to see if p…
Phase: NA • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New registry to monitor safety of LOBO device in bleeding emergencies
Knowledge-focused ENROLLING_BY_INVITATIONThis registry will follow 500 adults who receive the LOBO Vascular Occlusion System, a device used to block blood vessels in cases of arterial bleeding or other conditions. The goal is to see how safe and effective the device is in everyday medical practice. Participants are enro…
Sponsor: Okami Medical, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart Patients' hidden danger: risky drug mixes under the microscope
Knowledge-focused OngoingThis study tracks 120 adults with heart disease and at least two other long-term illnesses to see how often dangerous drug interactions happen. Researchers check medications, including over-the-counter and herbal products, and follow participants for a year. The goal is to unders…
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New X-Ray tech aims to slash radiation for heart patients
Knowledge-focused OngoingThis study compares a new X-ray system (Azurion R4.0) to an older version during heart procedures like angiography. The goal is to see if the new system lowers the radiation dose patients receive while still allowing doctors to work effectively. About 824 adults from several coun…
Phase: NA • Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Massive gene sequencing project aims to unlock secrets of heart disease
Knowledge-focused OngoingThis study is sequencing the genes of 1665 people aged 45 to 65 to learn how genetic changes relate to health, especially heart disease. Participants provide blood samples and undergo heart tests. The goal is to improve methods for interpreting genetic data and understand how res…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Massive study tests if insurance records can mimic Gold-Standard drug trials
Knowledge-focused OngoingThis study looks at healthcare claims from over 78,000 people to see if it can reproduce the results of the EINSTEIN-DVT trial, which compared two blood thinners (rivaroxaban and warfarin) for treating blood clots. The goal is not to test a new drug, but to learn whether real-wor…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Rehab program shows promise in tracking blood flow recovery
Knowledge-focused OngoingThis study looks at how blood flow in the feet changes during a 12-week heart and blood vessel rehab program for people with narrowed arteries. Researchers will track 80 adults with conditions like peripheral artery disease or coronary artery disease. The goal is to better unders…
Phase: NA • Sponsor: Laval University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Eye drop study reveals hidden changes in eye bacteria
Knowledge-focused OngoingThis study looks at how a common glaucoma eye drop (latanoprost with preservatives) changes the natural bacteria living on the eye's surface. Researchers will compare the eye bacteria of 45 newly diagnosed glaucoma patients before and after at least 6 months of treatment. The goa…
Sponsor: University of Ioannina • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Big data vs. clinical trials: can insurance records match gold-standard results?
Knowledge-focused OngoingThis study looks at health records of nearly 150,000 people who had knee replacement surgery to see if real-world data can reproduce the findings of a previous clinical trial (RECORD3). The researchers compare two blood thinners, rivaroxaban and enoxaparin, to see which better pr…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New tool could predict who will suffer from steroid side effects
Knowledge-focused OngoingThis study aims to create a tool that predicts which patients with inflammatory rheumatic diseases (like rheumatoid arthritis, vasculitis, or polymyalgia rheumatica) will develop serious side effects from long-term steroid use. Researchers will collect routine medical data—such a…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain bleed survivors studied for clot Removal's Long-Term brain benefits
Knowledge-focused OngoingThis study follows 350 people who survived a brain bleed (intracerebral hemorrhage) and were part of earlier trials. Researchers will test memory, thinking, and movement skills over time, and collect blood samples to look for signs of ongoing inflammation. The goal is to see if s…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can insurance records replace clinical trials? huge study puts it to the test
Knowledge-focused OngoingThis study is not testing a new treatment. Instead, researchers are checking whether information from healthcare claims (like insurance records) can produce the same results as a famous clinical trial called RECORD1. They are looking at data from over 89,000 people who had hip re…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Genetic heart risk alert: does knowledge lead to better health?
Knowledge-focused OngoingThis study looks at whether telling people they have a high genetic risk for heart disease helps them make healthier choices. About 200 adults without heart disease will be followed for one year. Researchers will compare heart health scores between those who learn their genetic r…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Heart valve mystery: scientists hunt for genetic clues in 1,000 patients
Knowledge-focused OngoingThis study collects tissue samples from 1,000 people having heart valve surgery to find genetic causes of calcific aortic valve disease. Researchers will compare normal and diseased tissue to understand why the disease develops. Participants must be at least 20 years old and have…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Heat therapy for leg pain study pulled before starting
Knowledge-focused TerminatedThis study was designed to see if a device called AirGlove, which applies heat, could improve blood flow in the legs of people with peripheral arterial disease (PAD). It planned to include healthy volunteers and people with PAD who experience leg pain when walking. However, the s…
Phase: NA • Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
10-Year heart study reveals Real-World balloon treatment results
Knowledge-focused OngoingThis study reviewed medical records of 1000 people who received a special balloon treatment (drug-coated balloon angioplasty) for blocked heart arteries between 2009 and 2015. Researchers tracked major heart problems like death, heart attacks, or need for repeat procedures for up…
Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Why do women have heart attacks without blocked arteries? new study investigates
Knowledge-focused OngoingThis study looks at women who have had a heart attack or unstable angina but do not have major blockages in their heart arteries. Doctors will use special imaging techniques, like IVUS and MRI, to find hidden causes such as cholesterol plaque in artery walls or problems with tiny…
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Massive Real-World study tracks roche eye drugs in 6,000 patients
Knowledge-focused OngoingThis study is collecting long-term, real-world data from about 6,000 adults being treated with Roche eye medications (Faricimab or the Port Delivery System with Ranibizumab) for conditions like wet age-related macular degeneration and diabetic macular edema. The goal is to unders…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Repeat CT scans after minor head injury: helpful or not?
Knowledge-focused OngoingThis study looks at 1,000 patients on blood thinners who had a minor head injury and a normal first CT scan. Researchers want to see if a second CT scan 24 hours later finds any delayed brain bleeding. The goal is to understand whether the extra scan is needed and how often it le…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Can kids regain full fitness after a blood clot? new study investigates
Knowledge-focused OngoingThis study looks at why some children and teens feel short of breath or have trouble exercising after their first blood clot in the leg (deep vein thrombosis) or lung (pulmonary embolism). Researchers will measure exercise capacity and breathing using special tests. The goal is t…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study aims to uncover why straining worsens hemorrhoids
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how straining affects people with bleeding hemorrhoids. Researchers will use surveys and a standard test called anorectal manometry to understand the link between pelvic floor problems and hemorrhoid symptoms. The goal is to help doctors give better treatment …
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Hidden killers in controlled hypertension: study probes why blood pressure meds aren't enough
Knowledge-focused OngoingThis study combines data from over 2,500 people with treated and controlled high blood pressure to understand why some still die from heart attacks, strokes, or kidney failure. Researchers are looking beyond blood pressure numbers to find other factors that might predict these fa…
Sponsor: DejthidaNathaphong • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Processed vs. natural: which diet wins for your heart?
Knowledge-focused TerminatedThis study looks at how eating mostly ultra-processed foods (like packaged snacks) compared to less-processed foods (like whole fruits and vegetables) affects blood pressure and other heart health markers. About 79 overweight adults will follow special diets to see the difference…
Phase: NA • Sponsor: USDA Grand Forks Human Nutrition Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
VHL tumor growth study aims to predict which lesions need surgery
Knowledge-focused OngoingThis 5-year study follows 250 people with von Hippel-Lindau disease who have brain or spinal cord tumors. Researchers use regular MRI scans and blood tests to see how fast tumors grow and what factors like hormones might affect growth. The goal is to better understand which tumor…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Heart CT scans may spot hidden fat and scar linked to dangerous rhythms
Knowledge-focused OngoingThis study uses advanced CT scans to look for fat and scar tissue inside the heart. Researchers want to see if these findings can help predict who is at risk for dangerous heart rhythms. About 110 adults with heart disease who already have a defibrillator or need one will get a C…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
15,000-Person study aims to sharpen heart risk predictions with CT scans
Knowledge-focused ENROLLING_BY_INVITATIONThis study is enrolling 15,000 adults who are already scheduled for a coronary CT angiography (CCTA) scan. Researchers will analyze the scan images along with participants' health outcomes over time. The goal is to see if detailed information from the scans can help doctors more …
Sponsor: Cleerly, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Heart attack survivors' kidneys under microscope in massive study
Knowledge-focused OngoingThis study examines how different hospital treatments—sedation, temperature control, and blood pressure management—after a cardiac arrest impact kidney function. Researchers will follow 3500 adults who were resuscitated from a heart attack outside the hospital. The goal is to und…
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Real-World study tracks cholesterol drug inclisiran in heart patients
Knowledge-focused OngoingThis observational study follows about 198 patients in Spain who are already taking inclisiran (Leqvio) for high cholesterol linked to heart disease or a genetic condition. Researchers will check if patients reach their LDL cholesterol goals after 6 and 12 months. The goal is to …
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Heart scan showdown: does extra stress imaging save time and money?
Knowledge-focused OngoingThis study looks at whether adding a stress CT scan that checks blood flow to the heart muscle helps doctors decide the best treatment for people with known or suspected heart disease. About 2000 adults will be followed to see if this extra test reduces the need for more tests an…
Phase: NA • Sponsor: Centro Cardiologico Monzino • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can a phone app slash pregnancy care costs? new study aims to find out
Knowledge-focused OngoingThis study looks at whether using a mobile health app (called Penelope) is a cost-effective way to manage high blood pressure disorders during pregnancy. About 250 pregnant women at risk for conditions like preeclampsia will either use the app or track their health on paper. Rese…
Phase: NA • Sponsor: Principal Engineering s.r.o. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Hidden danger: microplastics found in brain clots may worsen stroke outcomes
Knowledge-focused OngoingThis study looks for tiny plastic particles in brain tissue removed during surgery for spontaneous bleeding. Researchers will test if these plastics are linked to more inflammation and worse recovery in 150 patients. No new treatment is given; the goal is to understand if environ…
Sponsor: University of Campania Luigi Vanvitelli • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
ER study aims to keep Low-Risk clot patients out of hospital
Knowledge-focused OngoingThis study looks at whether a new care plan can help more people with pulmonary embolism (a blood clot in the lungs) go home from the emergency room instead of being admitted to the hospital. Researchers are working with 14 hospital ERs in Michigan to track changes in how often l…
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Hidden bone loss: HIV and cancer patients under the scanner
Knowledge-focused OngoingThis study looks at why people with HIV and certain cancers caused by KSHV (Kaposi sarcoma herpesvirus) may lose bone density faster. Researchers will review past CT scans and health records from 40 adults treated at the NIH between 2005 and 2020. The goal is to find factors link…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brain scan study to detect hidden inflammation in silent artery disease
Knowledge-focused TerminatedThis study was designed to use a special PET scan to measure brain inflammation in people with asymptomatic carotid artery disease (narrowing of neck arteries without symptoms). It aimed to compare inflammation levels between those with high-grade and low-grade narrowing. However…
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Hidden kidney trouble: high blood pressure study in kazakhstan aims to find the missing cases
Knowledge-focused OngoingThis study is tracking over 1,200 adults in Kazakhstan who have high blood pressure to see how many also have signs of chronic kidney disease (CKD). Researchers will measure things like protein in urine and kidney function. The goal is to understand how often CKD goes undiagnosed…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Smartwatches may predict migraines before they strike
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether data from wearable devices like smartwatches can track and even predict migraine headaches. Twenty adults with chronic migraine will use a phone app and a smart device to record heart rate and movement. The goal is to see if this information can help f…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Which drug lowers cholesterol better? new study compares alirocumab and inclisiran
Knowledge-focused OngoingThis study looks at two medicines, alirocumab and inclisiran, that help lower bad cholesterol (LDL-C) in people with heart disease. Researchers will use real-world data from about 124 patients to see which drug reduces cholesterol more over time. The goal is to understand how the…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New digital tool aims to simplify care for seniors with multiple conditions
Knowledge-focused OngoingThis study tests a web-based tool called gp-multitool.de that helps general practitioners follow guidelines for older patients with multiple chronic conditions. About 659 patients from GP practices in Germany are taking part. The tool lets patients fill out questionnaires online …
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to tackle vision problems in upper manhattan
Knowledge-focused TerminatedThis study aims to help adults aged 40 and older in Upper Manhattan get better eye care. It will offer free eye screenings at local health centers and senior centers, and provide support like scheduling appointments and transportation. The goal is to see if this extra help leads …
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study tests if better imaging during stent surgery improves heart outcomes
Knowledge-focused OngoingThis study looks at 320 people with complex coronary artery disease who need a stent. It compares using a special camera (OCT) versus standard X-ray (angiography) to guide the stent placement. The goal is to see which method leads to better blood flow after the procedure.
Phase: NA • Sponsor: Chonnam National University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Skin cells may reveal secrets of deadly aortic bulges
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at skin cells (fibroblasts) from people with Marfan syndrome and other genetic conditions that cause thoracic aortic aneurysms (a bulging of the main artery in the chest). Researchers want to find out how these cells behave differently and what genes or proteins …
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Researchers track Long-Term effects of carotid artery procedures
Knowledge-focused OngoingThis study follows up with people who took part in the CREST-2 trial to see how well treatments for carotid artery narrowing work over the long term. It includes about 2,480 participants who had either surgery, stenting, or intensive medical management. The main goal is to track …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Can a quick rehab visit cut stroke hospital stays?
Knowledge-focused OngoingThis study looks at whether having a rehabilitation doctor see stroke patients early in their hospital stay can shorten how long they stay and reduce the chance of coming back. Researchers are tracking 3,000 stroke patients to see if this coordinated care approach improves recove…
Sponsor: Deviyani Mehta, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New MRI study seeks hidden stroke causes in rare blood disorder
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why people with antiphospholipid syndrome (APS) — a condition that raises blood clot risk — may have narrowed brain arteries. Researchers will use advanced MRI scans on 60 APS patients to check for artery narrowing and plaque buildup. The goal is to better und…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Brain monitor may guide safer blood pressure during surgery
Knowledge-focused OngoingThis study looks at whether low blood pressure during major noncardiac surgery harms organs like the heart and kidneys. Researchers are using a non-invasive brain monitor to see if a personalized blood pressure target can be set. 650 patients at cardiovascular risk are being obse…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Cancer clot care under the microscope: new study mines data for better treatment insights
Knowledge-focused OngoingThis study reviews existing medical records to understand how blood clots (VTE) are treated in people with active cancer or a history of cancer. Researchers will look at which blood thinners are used, how often clots come back, and the costs involved. No new treatments are given—…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
War wounds may trigger hidden heart risks, new study reveals
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how serious combat injuries affect the long-term health of U.S. military members. Researchers will measure heart function, sleep quality, and stress-related body signals in 200 injured service members. The goal is to understand links between injury severity, s…
Sponsor: Uniformed Services University of the Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can a scan predict amputation risk? new study aims to find out.
Knowledge-focused OngoingThis study looks at whether special imaging features from scans can help predict serious outcomes like amputation or death in people with peripheral artery disease (PAD) after they have had a procedure to open blocked leg arteries. Researchers will analyze 200 patients' scans to …
Sponsor: Zhijun Bao • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Researchers track Long-Term safety of experimental eye cancer drug
Knowledge-focused OngoingThis registry follows 63 patients with choroidal melanoma or early eye lesions who were treated with the experimental drug bel-sar in earlier studies. The goal is to monitor long-term safety, side effects, and any spread of the disease over time. Participants are not receiving ne…
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Home workout study aims to boost heart health in black women
Knowledge-focused OngoingThis study tests whether a remotely delivered resistance training program is practical and helpful for Black women aged 30-64 who are overweight, have prediabetes or diabetes, or have high blood pressure. About 37 women will participate from home using their own devices. The goal…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Diabetes drug eye risk under microscope
Knowledge-focused OngoingThis study looks at how newer diabetes medications (SGLT2 inhibitors and GLP-1 receptor agonists) affect the eyes of people with type 2 diabetes. Researchers will monitor 40 adults who take metformin and are starting these newer drugs. The goal is to see if these drugs cause any …
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Massive study aims to improve survival after aortic tear surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects data from 1,200 patients undergoing surgery for aortic dissection, a life-threatening tear in the heart's main artery. Researchers will track death rates, strokes, and other complications to identify the safest surgical strategies. The goal is to improve outco…
Sponsor: Centre Cardiologique du Nord • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Brain scans may unlock migraine treatment success
Knowledge-focused OngoingThis study looks at whether brain scans can help predict which people with migraine will respond to a class of drugs called CGRP antibodies. Researchers used MRI to measure brain structure, activity, and blood flow in 219 adults with frequent migraine before and after 12 weeks of…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Silent heart damage after leg artery treatment? new study investigates.
Knowledge-focused OngoingThis study follows 500 people with peripheral artery disease (PAD) who undergo a procedure to open blocked leg arteries. Researchers check blood and heart ultrasound before and after the procedure to find hidden heart injury. The goal is to see if certain markers can predict futu…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Study pulled: music and meditation for heart bypass recovery never tested
Knowledge-focused TerminatedThis study aimed to see if music therapy and mindfulness meditation could help people who had coronary artery bypass surgery improve their blood pressure, heart rate, anxiety, and depression. It planned to enroll 48 adults who had the surgery and were stable. However, the study w…
Phase: NA • Sponsor: Universiti Tunku Abdul Rahman • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Heart MRI could predict when valve patients need surgery
Knowledge-focused OngoingThis study looks at whether a special MRI scan can detect early scarring in the heart muscle of people with leaky heart valves. The goal is to find a way to predict when the heart might start to fail, so doctors can decide on surgery sooner. About 316 adults with moderate to seve…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Gum disease may worsen high blood pressure, new study suggests
Knowledge-focused OngoingThis study follows 200 adults with high blood pressure and gum disease to see how gum health affects blood pressure and cholesterol levels over 6 to 12 months. Researchers will measure triglycerides and LDL cholesterol to understand the link. The goal is to learn whether treating…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Healthy volunteers help scientists map Brain's pain pathways for migraine insights
Knowledge-focused OngoingThis study uses brain scans to see how the brainstem and other brain areas respond to mild electrical pulses on the face and arm in 40 healthy volunteers. The goal is to better understand the brain circuits involved in facial pain and touch, which could help future research on mi…
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Rural clinics get help to catch diabetic eye disease early
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a program called I-SITE can help rural health clinics use teleophthalmology (remote eye exams) to screen more diabetic patients for eye problems. Up to 10 health systems and 10,000 patients will take part. The goal is to see if screening rates improve …
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
No-scope stomach check: magnetic camera tested for pre-surgery screening
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether a swallowable camera capsule, controlled by magnets from outside the body, can safely and effectively examine the stomach and esophagus in 30 people preparing for weight loss surgery. Participants swallow the capsule after fasting, and a surgeon guides it…
Phase: NA • Sponsor: Jerry Dang • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
AI could help heart surgery patients get the right Anti-Inflammatory drug
Knowledge-focused OngoingThis study is looking at whether an artificial intelligence tool can help doctors decide which heart surgery patients might benefit from a drug called ulinastatin. Ulinastatin is used to reduce inflammation after surgery, but it doesn't work for everyone. Researchers will analyze…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Brain imaging may reveal who benefits most from carotid surgery
Knowledge-focused OngoingThis study looks at 45 people having carotid artery surgery to see if special brain scans can predict improvements in thinking and memory. Researchers will use PET/CT scans to measure inflammation in the brain and MRI to examine plaque in the carotid artery. The goal is to find i…
Phase: PHASE2 • Sponsor: Scott Mcnally • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Heart patients face bleeding and clot risks after joint surgery – new study investigates
Knowledge-focused OngoingThis study tracks over 1,700 heart patients who had hip or knee replacement surgery. Researchers want to see how often bleeding or blood clots happen in the months after surgery. The goal is to find better ways to prevent these complications.
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Florida launches brain disease biobank to fuel future discoveries
Knowledge-focused OngoingThis study is creating a statewide collection of blood samples and medical information from people with various brain blood vessel diseases, such as stroke and dementia. The goal is to build a resource that scientists can use in future research to better understand and potentiall…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Tablet tool aims to boost pregnancy care in south asia
Knowledge-focused OngoingThis study tests whether a tablet-based decision support system helps frontline health workers in India and Nepal provide better antenatal care. About 1,320 pregnant women will take part. The tool guides workers to check blood pressure, blood sugar, urine protein, and hemoglobin,…
Phase: NA • Sponsor: Public Health Foundation of India • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New imaging technique could sharpen laser treatment for birthmarks
Knowledge-focused OngoingThis study uses a special imaging device called optical coherence tomography (OCT) to look at blood vessels in vascular stains (a type of birthmark). Researchers want to see if the size and depth of these vessels relate to the birthmark's genetics. About 73 people with vascular s…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Is 'Safe' snus actually safe? 30,000-Person study aims to find out
Knowledge-focused OngoingThis study uses data from over 30,000 Swedish adults to see if using snus (including newer white nicotine pouches) is linked to heart disease, metabolic problems, and poor mental health, independent of smoking. Researchers will compare current, former, and never-users using advan…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New study tracks Faricimab's Real-World impact on major eye diseases
Knowledge-focused OngoingThis study follows 1,000 patients in China who are already receiving faricimab for diabetic macular edema, retinal vein occlusion, or wet age-related macular degeneration. Researchers will collect data from routine clinic visits over one year to see how well the drug works and ho…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Protein power: new study probes link between diet and heart risk
Knowledge-focused OngoingThis study looks at how high-protein drinks affect certain blood cells (monocytes and platelets) that may play a role in heart disease. Ten healthy adults will drink either a low-protein, high-protein, or leucine-added meal, and researchers will check their blood for changes in c…
Phase: NA • Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
10-Year look at aneurysm device: will it hold up?
Knowledge-focused OngoingThis study follows 2000 people who received the AFX2 system, a device to repair abdominal aortic aneurysms. Researchers will track complications like rupture, need for further procedures, and death over 5 to 10 years. The goal is to see how well the device performs in real-world …
Sponsor: Endologix • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Japanese database study tracks Real-World use of eye injection aflibercept 8 mg
Knowledge-focused OngoingThis observational study examines how aflibercept 8 mg, an injection into the eye, is used in routine care for patients in Japan with age-related macular degeneration or diabetic macular edema. Researchers will analyze claims data from about 3000 patients to understand patient ch…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New study aims to sharpen heart scans by tailoring doses to body weight
Knowledge-focused OngoingThis study looks at whether giving a personalized dose of a radioactive tracer (rubidium-82) based on a patient's weight can improve the quality of PET heart scans. Researchers will enroll 48 adults with known or suspected heart disease and divide them into four weight groups. Th…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists create massive movement library to unlock secrets of brain and limb disorders
Knowledge-focused OngoingThis study collects movement data from 250 people with stroke, Parkinson's disease, or leg amputations using wearable sensors and video. The goal is to build an online database that researchers can use to study how people move and recover. No treatments are being tested—this is p…
Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Family history may raise risk of deadly aneurysm, swedish study suggests
Knowledge-focused OngoingThis study looks at whether brothers, sisters, and children of people who have had an abdominal aortic aneurysm are more likely to develop one themselves. Researchers will analyze health records from nearly one million people in Sweden. The goal is to better understand how family…
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Short step test may simplify fitness checks for lung patients
Knowledge-focused OngoingThis study looks at whether a 2-minute step test can accurately measure exercise ability in people with pulmonary hypertension, compared to the standard 6-minute walk test. Researchers will enroll 35 adults with the condition and measure oxygen use, heart rate, and breathlessness…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Massive study tracks heart damage after surgery in nearly 20,000 patients
Knowledge-focused OngoingThis study follows nearly 20,000 patients who had major non-cardiac surgery to see how often heart injury occurs and what happens a year later. Researchers are looking at death rates and major heart complications. The goal is to better understand who is at risk and how to improve…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC